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TraR is a transcription activator of the quorum sensing system in the plant 
pathogen Agrobacterium tumefaciens. This protein is composed of two 
domains: amino-terminal domain (NTD) which is responsible for binding the 
autoinducer OOHL and for dimerization and the carboxyl-terminal domain 
(CTD) which contributes less extensively to dimerization and binds to specific 
sequences in the DNA called tra boxes. Despite being one of the most studied 
proteins from the LuxR family, the mechanism of transcription activation and 
stability of TraR are not well understood. In the first part of this work, we 
construct mutations in amino acids in the NTD of TraR to find the ones 
involved in the contact with RNA polymerase. Two patches of amino acids 
were found. One of them is composed of amino acids that are important for 
class I and II promoters. Therefore, those amino acids might contact the 
alpha-CTD subunit of the RNA polymerase. The other patch has amino acids 
important only for class II promoters, indicating that they might contact alpha 
or sigma subunits of the RNA polymerase. The second part of this study 
shows that the CTD of TraR contains amino acids that destabilize the protein. 
The results indicate that amino acids that are exposed in monomer TraR, but 
 buried in the dimer protein, can provide protease recognition motifs. It was 
also shown that amino acids involved in RNA polymerase and DNA contacts, 
can also destabilize TraR. These results suggest that when bound to DNA or 
RNA polymerase, this amino acids would not be available for proteolysis. In 
the third part of this study, the effect of the antiactivator protein, TraM, in the 
stability of TraR was studied. The results show that TraR is degraded after 
antiactivation and that the levels of TraM do not change. Mutants that block 
antiactivation also block TraR proteolysis. The results suggest that TraM is an 
adaptor protein which delivers TraR to proteases, increasing its degradation 
rate.   
 
 iii 
BIOGRAPHICAL SKETCH 
Esther Dantas Costa was born on January 29th 1982 in Viçosa, Minas Gerais in the 
southeastern part of Brazil. At the age of 3, she moved to Paranã, Tocantins, a beautiful 
city in the north of Brazil, with two big rivers, only one public school, no pavement, 
electricity for only a few hours a day and lots of snakes. She lived there for almost ten 
years. This made for a very fun childhood for her and for sure had a big influence in her 
character. In 1994, she moved back to Viçosa where she graduated from Equipe high 
school. In 1999, she was admitted to the Universidade Federal de Viçosa, majoring in 
Food Engineering in 2004. During four years of her undergraduate studies, she worked 
at the Food microbiology Lab, where she received a scientific initiation fellowship from 
the Brazilian government (CNPq). In 2004 she started the Master’s program in 
Agricultural Microbiology also at Universidade Federal de Viçosa with an award from 
CNPq. She then decided to study abroad and won a fellowship to come to the United 
States to pursue a PhD. She received her M. Sc. in 2006 and came to Cornell 
University in the same year where she joined the laboratory of Dr. Stephen C. Winans in 
August of 2006.   
 iv 
 
 
 
 
 
 
 
 
 
 
 
 
Para os meus queridos pais, Denise e Simião, e avós, Esther  e  Sebastião 
 
 v 
ACKNOWLEDGMENTS 
 
I would like to thank everybody that contributed, directly or indirectly, to the completion 
of this work. I have met a lot of wonderful people in the 5 years that I spent in Ithaca and 
have grown both personally and professionally. 
First, I would like to thank my advisor, Steve Winans, for the great ideas and support, 
and also for giving me the opportunity to do my PhD in his lab. I do not know anybody 
that loves science more than he does.  
I would also like to thank my PhD committee members Dr. Alan Collmer (Plant 
Pathology) and Dr. Linda Nicholson (Biochemistry), who were both very encouraging 
and helpful. They are amazing scientists who taught me so much in their classes and 
during our discussions.  
There are also many others who I would like to thank: 
Dr. Anatol Eberhard for all of our discussions (scientific, and non-scientific!). These 
made life in the lab more enjoyable. 
I thank current and past members of the Winans Lab, especially Uelinton, Ana Lidia, 
Gina, Sonny and Nydia, for all the teamwork, for sharing space and knowledge 
whenever needed, and mainly for their friendship. I thank Nathan and Tom for keeping 
the lab in such good shape. 
I also would like to thank all the laboratories at the microbiology department for sharing 
equipment and knowledge. In particular I would like to thank the Helmman Lab who 
share the floor with us, especially Veronica and Yun. Thanks Ahmed, for being in a 
good mood all the time and for helping me with advice and psychological support. 
The secretaries, Shirley Cramer, Doreen Dineen, Patti Butler and Cathy Shappell for all 
 vi 
the help. Without you this work would not have been possible. 
All my dear friends that I could write pages and pages about. I would like that you all 
know that without you, I would not be here. 
Finally, I would like to thank the most important people in my life: my family and my 
partner in everything, Colman. Thanks for all the unconditional love, patience and 
support. They were my pillars during the 5 years of my PhD studies.  
 
 
 
 
 
 
 
 
 
 
  
 vii 
TABLE OF CONTENTS 
 
Biographical Sketch iii 
Dedication IV 
Acknowledgements V 
Table of Contents Vii 
List of Figures Xii 
List of Tables XiV 
  
CHAPTER 1. Introduction  
1.1. Cell-cell communication in bacteria 1 
1.2. Agrobacterium tumefaciens 3 
1.3. Quorum sensing in A. tumefaciens 7 
1.4. Transcription activation by TraR 18 
1.5. TraR regulation 22 
1.5.1. OOHL 22 
1.5.2. TraR dimerization 23 
1.5.3. Antiactivation of TraR 25 
TrIR 25 
TraM 26 
1.6. Contents of the dissertation 29 
1.7. References 31 
 
 viii 
CHAPTER 2. Identification of Amino Acid Residues of the Pheromone-binding 
Domain of the Trascription Factor TraR that are Required for Positive Control  
 
2.1. Summary  41 
2.2 Introduction 42 
2.3. Results 47 
Mutagenesis of residues in the N-terminal domain of TraR 47 
Activity of TraR mutants in vivo 49 
In vivo accumulation of mutant proteins 51 
Ability of TraR mutants to bind DNA fragments containing tra box sequences 54 
Activity od site-directed mutants at a class I promoter 57 
Intragenic complementation of TraR mutants 58 
2.4. Discussion 60 
2.5. Experimental Procedures 67 
Bacterial Strains and plasmids 67 
DNA manipulations and strain constructions 68 
Site-directed mutagenesis 69 
In vivo assays for TraR activity 69 
Immunodetection of TraR 70 
Gel mobility shift assays 71 
Intragenic complementation 72 
Structural analyses 72 
2.6. References 74 
2.7. Supplementary Information 80 
 ix 
CHAPTER 3. The DNA Binding Domain of TraR Contains Amino Acid 
Residues that Increase Protease Susceptibility 
 
3.1. Summary 90 
3.2. Introduction 91 
3.3. Materials and Methods 93 
Bacterial strains, plasmids and oligonucleotides 93 
DNA manipulations 94 
Immunodetection of TraR in vivo 98 
OOHL sequestration assay by TraR in whole cells 98 
TraR stability in E. coli 99 
Overexpression of MBP-TraRCTD 99 
Random mutagenesis PCR 100 
Site-directed mutagenesis 100 
Protease deficient strains 101 
3.4. Results 102 
TraR(1-170) is more stable than full length TraR 102 
TraRCTD destabilizes MBP and GFP fusion proteins 106 
Identification of TraRCTD residues that enhance proteolysis 109 
Clp, Lon and HslVU cause proteolysis of GFP-TraRCTD 117 
Other amino acids of TraRCTD decrease protein stability 118 
3.5. Discussion 121 
3.6. References 125 
 
 x 
CHAPTER 4. The Antiactivator Protein TraM Targets the Quorum Sensing 
Transcription Activator TraR to Proteolysis 
 
4.1. Summary 130 
4.2. Introduction 131 
4.3. Materials and Methods 133 
Bacterial strains, plasmids and oligonucleotides 133 
DNA manipulations 134 
Plasmids construction 135 
Site-directed mutagenesis 136 
Immunodetection of TraR 136 
OOHL sequestration assay by TraR in whole cells 137 
4.4. Results 138 
TraM enhances TraR proteolysis 138 
Accumulation of TraR in the presence of TraM increases when the protein 
binding between TraR and TraM is impeded 
141 
TraM levels do not decrease with increasing amounts of active TraR 143 
The traM leader sequence contains 300 nucleotide highly conserved sequence                                                                               144
4.5. Discussion 149 
4.6. References 152 
  
CHAPTER 5. Conclusions and Future Work Directions 156 
  
 
 xi 
APPENDIX. Saturation Mutagenesis of a CepR Binding Site as a Mean to 
Identify New Quorum-regulated Promoters in Burkholderia cenocepacia 
 
A.1. Summary 159 
4.2. Introduction 160 
A.3. Results 167 
Systematic mutagenesis of a CepR-dependent promoter 167 
A.4. Discussion 170 
A.5. Experimental Procedures 170 
Bacterial strains and growth conditions 170 
Systematic mutagenesis of the cepI promoter 170 
A.6. References 176 
 
 xii 
LIST OF FIGURES 
 
Figure 1.1. The genes of the octopine-type Ti plasmid and their organization 5 
Figure 1.2. Signal molecules used in bacterial signaling 9 
Figure 1.3. The Quorum sensing mechanism in V. fischeri 11 
Figure 1.4. The TraR-TraI regulon in the octopine-type Ti plasmid 15 
Figure 1.5. Crystal Structure of a TraR dimer complexed to OOHL 17 
Figure 1.6. Transcription regulation by TraR on the octopine-type Ti plasmid 21 
Figure 1.7. Illustration of TraR proteolysis 24 
Figure 1.8. Interactions between TraM and TraR 28 
Figure 2.1. Saturation mutagenesis of the surface of the NTD of TraR 48 
Figure 2.2.  Western immunoblot data of TraR point mutants in A. tumefaciens 
strain NTL4 (pCEW260) 
52 
Figure 2.3.  Electrophoretic mobility shift assays with TraR in crude cell extracts 55 
Figure 2.4.  Intragenic complementation of mutations of D10, G123, and W184 59 
Figure 2.5.  Positive control mutants isolated in this study (in the TraR NTD) and 
in a previous study (TraR-CTD) 
63 
Figure 2.6.  Closeup views of TraR residues required for positive control 65 
Figure 3.1. N-terminal domain of TraR is more stable than the full-length TraR 104 
Figure. 3.2.  C-terminal domain of TraR bears proteolytic signals 107 
Figure. 3.3. Fluorescence of GFP-TraRCTD fusion protein and genetic screen for 
amino acid residues in TraR-CTD that contain proteolytic signals 
108 
Figure 3.4. Fluorescence Intensity of GFP-TraR(CTD) variants bearing truncations 
and substitutions in the first protease recognition motif (PRM) 
112 
Figure 3.5.  Fluorescent activities from E. coli cells expressing different GFP-
TraRCTD variants 
114 
 xiii 
Figure 3.6. Fluorescence activities of GFP-TraR(CTD) variants bearing mutations 
and substitutions in the second protease recognition motif (PRM) 
115 
Figure 3.7. Structure of TraR-CTD with highlighted regions representing the first 
putative protease recognition motif (183-RWIAV-187) and the second recognition 
motif (233-LI-234) in TraR-CTD 
116 
Figure 3.8. Model of Clp protease function 117 
Figure 3.9. E. coli wild type and protease deficient strains expressing either GFP 
or GFP-TraRCTD fusion proteins 
118 
Figure 3.10. Accumulation and half-life of each mutant in full length TraR 120 
Figure 4.1. TraR degradation with increasing amounts of TraM 139 
Figure 4.2. TraR sequesters less OOHL in the presence of TraM 141 
Figure 4.3. Accumulation of TraM, TraR wild type and mutants 142 
Figure 4.4. The presence of TraR does not change TraM stability 144 
Figure 4.5. Alignment of eight traM genes with upstream regions 146 
Figure 4.6. Conservation of the leader sequence of traM in different plasmids 147 
Figure 4.7. Predicted secondary structure of the traM leader of pTiR10 148 
Figure A.1. Mutagenesis of individual nucleotides in the cepI promoter 169 
 
 
 
 
 
 
 
 
 
 xiv 
LIST OF TABLES 
 
Table 2.1.  Mutations in the TraR N-terminal Domain that are defective in 
transcription 
50 
Table 2.2.  Accumulation in A. tumefaciens and DNA-binding affinity in vitro of all 
transcription-defective mutants 
53 
Table 2.3.  Activity of TraR mutants at the TraM promoter 56 
Table 2.4.  Intragenic complementation of positive control mutations of TraR 59 
Table 2.5.  Strains and plasmids used in this study 68 
Table S1: Summary of Mutant Phenotypes 80 
Table S2: Oligonucleotides used in this study 83 
Table 3.1.  Strains and plasmids used in this study 95 
Table 3.2. Oligonucleotides used in this study 97 
Table 3.3.  Distribution of identified nonsense mutations in GFP-TraR(CTD) stable 
variants among the 17 codons that can be converted to a stop codon by single 
base change 
110 
Table 4.1. Bacterial strains and plasmids used in this study 134 
Table 4.2. Oligonucleotides used in this study 136 
Table 4.3. TraR accumulation 140 
Table 4.4. Accumulation of TraR wild type and mutants, L182F, A195T and 
A195V, in the presence or absence of TraM 
143 
Table A.1. Strains and plasmids 171 
Table A.2. Oligonucleotides 173 
 
 
1 
CHAPTER 1 
Introduction 
 
1.1. Cell-cell communication in bacteria 
In the past it was believed that bacteria worked as single cells 
independent of one another, and that the phenotypes expressed by each cell 
did not depend on the other bacteria present in their environment.  In the 
1960s and 1970s however, studies on Streptococcus pneumonia and Vibrio 
fischeri revealed that certain bacterial traits were expressed only after a 
particular bacterial cell density was reached (Nealson et al., 1970; Tomasz, 
1965). This suggested that the bacteria had some means to communicate with 
each other, and were not acting in isolation. 
Within a few years, pheromone-like extracellular products involved in 
this cell-cell communication were identified (Eberhard et al., 1981; Lazazzera 
and Grossman, 1998). This opened the door for the investigation of the 
mechanisms and processes behind this type of communication. 
For many years, this communication phenomenon was believed to only 
play a role in a limited number of organisms. However, in the 1990s several 
researchers observed similar phenomenon in a wide range of different 
bacterial species, including in Agrobacterium tumefacies (Atkinson et al., 
1999; Beck von Bodman and Farrand, 1995; Fuqua and Greenberg, 1998; 
Fuqua et al., 1994; Gray et al., 1996; Latifi et al., 1995; Lazazzera and 
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Grossman, 1998; Lewenza et al., 1999; Lindum et al., 1998; Piper et al., 1993; 
Puskas et al., 1997; von Bodman et al., 1998).  
In 1994, the term “quorum sensing” was coined to describe this 
communication, reflecting the idea that bacterial cells carry out certain 
behaviors only if and when they reach some minimum cell population density, 
or “quorum” (Fuqua et al., 1994).  These regulatory systems, by using 
diffusible pheromones, provide a mechanism for bacteria to gauge their 
population densities, and to initiate gene expression only at high cell densities.  
Since then, the term “quorum sensing” (QS) has been widely adopted to 
describe cell-cell communication in bacteria, yeast, insects, and vertebrates. 
During the 1990s, the accelerated pace of research on quorum sensing 
enabled much improved understanding of the process. This in turn aroused 
the interest of the scientific community to the many possible applications of 
QS. These potential applications include uses in the production of 
biochemicals, tissue engineering and mixed-species fermentations 
(Choudhary and Schmidt-Dannert, 2010). Use of QS-inhibitors also has the 
potential to control the expression of virulence genes in pathogenic bacteria, 
thereby preventing disease (Ni et al., 2009; Njoroge and Sperandio, 2009). 
 
 
 
 
3 
1.2. Agrobacterium tumefaciens 
This dissertation will mainly focus on the bacterium A. tumefaciens 
where quorum sensing has been seen to play a role in the conjugation and 
replication of the tumor-inducing (Ti) plasmid (Fuqua and Winans, 1994; Li and 
Farrand, 2000; Pappas and Winans, 2003b). 
 A. tumefaciens belongs to the Rhizobiaceae family of the 
alphaproteobacteria group, which also includes nitrogen-fixing symbionts of 
legumes (Goodner et al., 2001; Slater et al., 2009; Wood et al., 2001). A. 
tumefaciens causes crown gall tumor in plants (Smith and Townsend, 1907), 
and is a problem in the agricultural industry since infected plants show 
decreased productivity (Escobar and Dandekar, 2003).  A. tumefaciens has 
the unique ability to modify the genome of host plants (Chilton et al., 1977; 
Winans, 1992).  This bacterium is used as a model organism for horizontal 
gene transfer, type IV secretion, plant-bacteria signaling, and quorum sensing 
(Farrand et al., 2002; Zhu and Winans, 2001). 
The genome of A. tumefaciens strain C58 (biovar I) was sequenced in 
2001 and is composed of two chromosomes, one linear and one circular, and 
two plasmids (Goodner et al., 2001; Wood et al., 2001). Other two genomes of 
this genus were sequenced in 2009,   from strain A. radiobacter K84 (biovar II) 
and strain A. vitis S4 (biovar III) (Slater et al., 2009). The Tumor-inducing (Ti) 
plasmid from biovar I is going to be the focus of this section because it 
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contains both the tumor-inducing and the quorum sensing genes, which are of 
particular interest in the context of this work. 
The Ti plasmid is approximately 200 Kb in length and contains most of 
the genes required for crown gall formation.  A set of genes denoted vir genes 
direct the processing and transfer a piece of oncogenic DNA (T-DNA) to 
genome of the host plant. This T-DNA is then integrated into a chromosome of 
the host.  Ti plasmids from different strains of A. tumefaciens are classified by 
opine type. The octopine (including A6 and R10 strains) and the nonpaline Ti 
plasmids (including C58 strain) are the most studied ones. The genes 
encoded by pTiR10 can be viewed in Figure 1.1 (Zhu et al., 2000). The main 
regions of this plasmid are: T-DNA region which has 25 bp unique border 
regions, not present any place else in the genome; virulence (vir) region which 
is responsible for processing and transferring the T-DNA from the bacteria to 
the plant cell; replication and partitioning (rep) region; and the tra and trb loci, 
which are involved in the conjugation of the plasmid. The plasmid also 
encodes genes responsible for the uptake and the catabolism of opines, which 
allows the bacteria to use the opines produced by the host plant after infection. 
Some opines are derivatized amino acids, while others are novel 
carbohydrates (Oger and Farrand, 2001; Zhu et al., 2000). 
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Figure 1.1. The genes of the octopine-type Ti plasmid and their organization. 
The genes shown above the scale are transcribed from left to right while the 
ones transcribed from right to left are below the scale. Green bars indicate 
genes that are transferred to plant cells. Red bars indicate genes in the vir 
regulon, regulated by VirA and VirG, and required for T-strand processing and 
transfer. Purple bars indicate genes required for conjugation of the Ti plasmid. 
Light green bars indicate genes required for replication and partitioning of the 
Ti plasmid. Dark blue bars indicate genes encoding opine permeases. Light 
blue bars indicate genes involved in opine catabolism. Orange bars indicate 
regulatory genes. Black bars indicate suspected IS elements and grey bars 
indicate ORFs of miscellaneous or unknown function. Figure from Zhu et al. 
(Zhu et al., 2000). 
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Exudates from the host plants, including phenolic compounds, such as 
acetosyringone, sugars and acidity, are detected by periplasmic sugar-binding 
protein called ChvE and by a two-component signal transduction system 
composed of two proteins encoded in the Ti plasmid, VirA and VirG (Huang et 
al., 1990; Winans et al., 1986; Winans et al., 1994). Upon detection of the 
signals, a phosphorylation cascade is activated where VirA, a transmembrane 
histidine kinase, transfers a phosphoryl group to VirG, which is the response 
regulator.  Phosphorylated VirG can activate transcription of other vir genes 
(Gelvin, 2006, 2009).  
The vir regulon has approximately 30 genes, most of which encode 
proteins necessary for the transfer and integration of the T-DNA into the plant 
cell nucleus. The T-DNA is processed by VirD2, which forms a complex with 
the T-DNA by binding to its 5’ end (Stachel et al., 1986). VirE2 binds to the 
entire surface of the single stranded T-DNA (Citovsky et al., 1997). The 
complex VirD2-T-DNA-VirE2 is transferred to the plant using a type IV 
secretion system formed by proteins of the virB operon and VirD4 (Cascales 
and Christie, 2003; Gelvin, 2009).  VirD2 and VirE2 have nuclear localization 
signals, which are recognized by the host and the protein-DNA complex is 
translocated to the nucleus (Ballas and Citovsky, 1997; Citovsky et al., 1992; 
Howard et al., 1992). Once in the nucleus, the T-DNA is integrated randomly 
into the plant chromosome by illegitimate recombination (Mayerhofer et al., 
1991).  
7 
The T-DNA contains approximately 15 genes, some of which play a 
variety of roles in uncontrolled cell proliferation, and the formation of the 
tumors characteristic of crown gall disease (Escobar and Dandekar, 2003).  
Other transferred genes direct the production of novel compounds called 
opines, which diffuse out of the plant, and serve as a nutrient for the bacteria.   
The opines produced by the host plant not only serve as nutrients for 
the bacteria, but also provide signals for the activation of the genes related to 
quorum sensing.  Quorum sensing in this bacterium is responsible for the 
conjugation and replication of the Ti plasmid (Fuqua and Winans, 1996b; Piper 
et al., 1999). Quorum sensing in A. tumefaciens is described in detail in 
section 1.3. 
 
1.3. Quorum sensing in A. tumefaciens 
During quorum sensing, bacteria communicate with each other and 
coordinate their behavior by responding to chemical molecules, also known as 
signal molecules, pheromones or autoinducers (Fuqua and Greenberg, 2002; 
Waters and Bassler, 2005; Whitehead et al., 2001). These signals are used by 
a bacterium to monitor the cell density in its neighborhood and this information 
is then used to guide the bacteria to behave in a particular way. The signal 
molecules vary according to the bacterial group. Acyhomoserine lactones 
(AHLs) are normally the mediators of communication in Gram negative 
bacteria while for Gram positive species, small peptides are involved in 
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signaling (Fuqua et al., 2001; Lazazzera and Grossman, 1998; Platt and 
Fuqua, 2010; Waters and Bassler, 2005; Whitehead et al., 2001).  In addition, 
a molecule called autoinducer 2 (AI-2) is commonly believed to be a signal for 
many groups of bacteria, however there is still some controversy surrounding 
this issue (Bassler et al., 1997; Fuqua and Greenberg, 2002; Ng et al., 2011; 
Rezzonico and Duffy, 2008). New signals and signaling systems are being 
discovered every year and it is expected that new families of signals will be 
discovered in the coming years. Bacterial quorum sensing signals already 
described are summarized in Figure 1.2 and include gamma-butyrolactones, 
fatty acids, fatty acid esters, quinolones and CAI-1 family (Winans, 2011).  
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Figure 1.2. Signal molecules used in bacterial QS signaling.  (A) CAI-1 (3-
hydroxytridecan-4-one, V. cholerae). (B) Am-CAI-1; (3-aminotridecan-4-one, 
V. cholerae). (C)  Ea-CAI-1 (3-enaminotridecan-4-one, V. cholerae). (D) LAI-1 
(3-hydroxypentadecan-4-one, Legionella pneumophila). (E) cis-decenoic acid, 
(P. aeruginosa). (F)  DSF (11-methyl-cis-dodecenoic acid, X. campestris). (G) 
OOHL (3-oxo-octanoylhomoserine lactone, A. tumefaciens). (H)  ComX 
(isoprenylated peptide, B. subtilis); (I) CSF (unmodified pentapeptide, B. 
subtilis). (J) AIP-1 (thiolactone peptide, S. aureus); (K) PAME (palmitic acid 
methyl ester, R. solanacearum). (L) A1-2 ((2R,4S )-2-methyl-2,3,3,4-
tetrahydroxytetrahydrofuran, ubiquitous). (M)  PQS (2-heptyl-3-hydroxy-4-
quinolone, P. aeruginosa). (N) A-factor (Streptomyces spp.). Figure modified 
from (Winans, 2011). 
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Quorum sensing was described for the first time in the marine bacteria 
Vibrio fischeri, which is a symbiont of various marine animals (Nealson et al., 
1970; Nealson and Hastings, 1979). The quorum sensing system in this 
bacterium became the paradigm and it is illustrated in Figure 1.3.  In this 
system, a protein called LuxI (known as the autoinducer synthase) produces 
the signal molecule N-3-oxohexanoyl-L-homoserine-lactone (OHHL) 
(Eberhard et al., 1981).  OHHL diffuses passively from the cells into the 
surroundings.  The LuxR protein is an OHHL receptor and OHHL-dependent 
transcription factor.  The presence of OHHL enables LuxR to form a dimer, 
which in turn binds to the luciferase promoter region and activates 
transcription of genes responsible for bioluminescence (Antunes et al., 2007; 
Pappas et al., 2004; Waters and Bassler, 2005; Whitehead et al., 2001).  The 
amino terminal domain of LuxR binds to OHHL with a dissociation constant of 
100 nM (Urbanowski et al., 2004) and mediates dimerization while the C-
terminal domain binds to a 20-base-pair inverted repeat termed lux box 
centered 42.5 nucleotides upstream of the transcription start site of the lux 
operon (Antunes et al., 2008; Urbanowski et al., 2004).  
At low cell densities, the concentration of OHHL is not enough to 
activate LuxR so the communication chain is not activated.  At a sufficiently 
high population, OHHL molecules accumulate such that their efflux is 
balanced by an influx.  OHHL then binds to LuxR, converting it to an active 
form.  In this way, the bacterium learns of, and responds to, the presence of a 
high concentration of nearby bacteria of the same species.  
11 
 
 
 
 Figure 1.3. The Quorum sensing mechanism in V. fischeri. At low cell density, 
the autoinducer synthase LuxI synthesizes N-3-oxohectanoyl-L-homoserine 
lactone (OHHL - red circles) which diffuses across the membrane. When a 
high cell density is reached, the OHHL accumulates inside the cells, binds to 
the transcription activator LuxR. LuxR-OHHL complexes form dimers which 
bind to target DNA, called lux boxes, activating transcription of luxI, the 
autoinducer synthase, and luxCDABE which are responsible for 
bioluminescence. 
lux  box luxICDABEluxR
LuxR
LuxR LuxR
Light
Luciferase
Autoinducer - OHHL
Autoinducer synthaseLuxI
LuxR-OHHL dimer 
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Proteins from the LuxR/LuxI family are present in many proteobacteria, 
including in A. tumefaciens, and they regulate many different phenotypes, 
including biofilm formation, pathogenesis, and production of secondary 
metabolites (Fuqua et al., 2001; Miller and Bassler, 2001; Waters and Bassler, 
2005; Whitehead et al., 2001). In these systems, the signal molecule is 
produced by a synthase that resembles LuxI and is detected by a protein that 
resembles LuxR.  In most cases, the signal molecule converts its receptor to 
an active form. However, there are some exceptions to this. In some cases, 
the signal converts the receptor to an inactive form that dissociates from the 
DNA (Tsai and Winans, 2010).  Proteins of this family include the EsaR of 
Pantoea stewartii, ExpR of Pectobacterium carotovorum and Erwinia 
chrysanthemi, SmaR of Serratia sp., YenR of Yersinia enterocolitica, PsyR 
and AhlRI of Pseudomonas syringae (Carlier et al., 2009; Castang et al., 2006; 
Cui et al., 2005; Fineran et al., 2005; Minogue et al., 2002; Minogue et al., 
2005; Schu et al., 2009; Sjoblom et al., 2006; Tsai and Winans, 2010, 2011). 
Some of the characteristics of these proteins reviewed by Tsai and Winans 
(Tsai and Winans, 2010) are: 
 Bind preferentially to OHHL (SmaR of P. Carotovorum is an 
exception and preferentially binds BHL 
  Do not have any effect on the synthase genes, differently from 
the LuxR-type proteins which normally activate expression of 
their cognate AHL synthase genes 
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 Can function as repressors (although some can also activate 
certain promoters) 
 Are encoded by genes that are adjacent and convergently 
transcribed from their cognate AHL synthase genes.   
Another variation is the so called orphan receptors, which are proteins 
from the LuxR family that are encoded, but do not have a cognate synthase 
coupled to them. These receptors are believed to work independently of the 
signal molecule producer and are believed to be able to recognize AHLs or 
other small molecules present in the environment (Lee et al., 2006; Patankar 
and Gonzalez, 2009; Subramoni and Venturi, 2009).  Salmonella and E. coli 
encode a LuxR homologue called SdiA, but they do not synthesize AHLs. SdiA 
can detect AHLs produced by other species of bacteria, being a good example 
of an orphan receptor protein (Dyszel et al., 2010; Noel et al., 2010; Soares 
and Ahmer, 2011; Sperandio, 2010). 
In the case of Agrobacterium tumefaciens, a protein called TraI 
synthesizes N-3-oxooctanoyl-L-homoserine lactone (OOHL) (Figure 1.2) which 
is detected by a protein called TraR, which is a transcription activator. These 
two proteins are encoded on the Ti plasmid.  
Opines are necessary for the transcription of TraR, and for this reason 
the quorum sensing system is only activated in the tumor environment, where 
these molecules are present in abundance.  One such opine, octopine, 
switches the transcription activator OccR from an inactive to an active state. In 
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the latter state, OccR activates transcription of the occQ operon, which 
includes proteins involved in the uptake and catabolism of opines and TraR 
(Akakura and Winans, 2002; Fuqua and Winans, 1996b; Habeeb et al., 1991). 
TraR is not only controlled by the presence of opines, but also in a post-
transcription level by OOHL, and by the antiactivator proteins TraM and TrlR 
(see section 1.5 for more details). 
TraR and TraI control the replication and conjugation of the Ti plasmid.  
One of the genes in the conjugation (tra) operon is TraI, which is the OOHL 
synthase and is positively regulated by TraR, creating a positive feedback 
loop, also observed in the V. fischeri and other bacteria (Fuqua and Winans, 
1994; Whitehead et al., 2001).  Figure 1.4 presents a model of the regulation 
of the quorum sensing system in A. tumefaciens. The activation of genes 
involved in conjugation and replication is discussed in more detail in section 
1.4. 
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Figure 1.4. The TraR-TraI regulon in the octopine-type Ti plasmid. The 
octopine produced by the host plants acts as a signal that activates the 
regulator protein OccR. OccR-octopine complex activates the transcription of 
traR. TraR binds to OOHL, which is the quorum sensing signal produced by 
TraI. TraR-OOHL binds as a dimer to specific sequences of DNA called tra 
boxes, triggering the transcription of genes responsible for conjugation (tra 
and trb) and replication (rep) of the Ti plasmid. Another gene regulated by 
TraR is traM, which encodes an antiactivator protein which is discussed in 
detail below. TraR-OOHL complexes can also be inactivated by TrlR, which is 
regulated by the transcription activator MocR in the presence of mannopine. 
AttM is a lactonase which inactivates AHLs, such as OOHL, by opening the 
lactone ring.   
OOHL
Octopine Mannopine
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The crystal structure of TraR was published by two groups in 2002 
(Vannini et al., 2002; Zhang et al., 2002).  The crystal structure shows TraR 
complexed to OOHL and tra box DNA (Figure 1.5). The OOHL is engulfed by 
the protein in a hydrophobic pocket having no contact with the solvent.  The 
protein binds to DNA as a dimer, and both domains contribute for dimerization.  
Each monomer of TraR has two domains: the amino terminal domain (NTD) 
which binds tightly to one molecule of OOHL and the carboxy terminal domain 
(CTD) which binds to DNA.  The NTD and CTD of TraR are linked by a 
flexible, twelve amino acid long linker (Zhang et al., 2002). The details of the 
binding between TraR and OOHL and dimerization are discussed in section 
1.5 because they are related to the regulation of the levels of TraR in the 
bacterial cells. 
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Figure 1.5. Crystal Structure of a TraR dimer complexed to OOHL and bound 
to its target DNA, tra box (pdb code: 1L3L). The NTD of TraR, represented by 
the blue and green helices, has the OOHL binding domain, indicated on the 
right monomer and the dimerization domain (helices α-9). The CTD of TraR, 
represented by the orange and red helices, binds DNA using a helix-turn-helix 
motif to specific sequences of DNA called tra boxes. The DNA recognition 
helix, α-12, is indicated (Zhang et al., 2002). 
 
 
 
 
 
α-9 
α-9 
α-13 α-13 
α-12 
α-12 
OOHL 
tra box DNA  
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1.4. Transcription activation by TraR 
As discussed above, TraR activates Ti plasmid genes responsible for 
conjugative transfer (tra and trb) and vegetative replication (rep) (Cho et al., 
2009; Fuqua and Winans, 1994; Li and Farrand, 2000; Pappas and Winans, 
2003b). TraR binds using a helix-turn-helix (HTH) motif to 18-nucleotide 
palindromic DNA sequences called tra boxes.  Each subunit of the dimer binds 
half of the tra box (Figure 1.6).  The contributions of each nucleotide of the 
consensus tra box and of each amino acid from the HTH motif were evaluated, 
and both specific and non-specific interactions between TraR and DNA were 
found.  The analysis also showed the presence of a sequence in the center of 
the tra box that does not contact TraR but which is nonetheless important for 
TraR-DNA affinity, possibly by facilitating bending and flexibility of the DNA 
(White and Winans, 2007).  Some tra boxes are centered -43.5 nucleotides 
upstream of the transcription start site; such promoters are referred to as 
Class II promoters.  Other tra boxes bind to a site centered 65.5 nucleotides 
upstream and are referred to as Class I promoters.  This classification was first 
used for the catabolic repressor protein (CRP) of E. coli which is a model 
system for transcription activation in class I and II promoters (Busby and 
Ebright, 1999). 
TraR regulates a total of seven promoters by binding to specific sites at 
the DNA called tra box I, tra box II, tra box III and tra box IV.  Two of the 
promoters are classified as class I promoters and five as class II promoters 
(Figure 1.6).  The operons controlled by TraR are: 
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 traAFBH and traCDG-yci (Fuqua and Winans, 1996a): controlled by TraR-
OOHL bound to tra box I, which is located -43.5 nucleotides upstream of 
the two divergent transcription start sites. These target genes direct DNA 
processing during conjugation. 
 traI-trb operon: traI-trb encodes genes involved in mating pair formation, 
the type IV secretion system for DNA transfer and entry-exclusion, as well 
as the pheromone synthase gene traI (Cho et al., 2009; Fuqua and 
Winans, 1996a). The genes are regulated from tra box II which is also 
between two divergent class II promoters.  
 repABC operon:  The repABC genes are responsible for replication and for 
the partitioning of the Ti plasmid into daughter cells.  RepA and RepB are 
involved in partitioning and RepC is the replication initiator protein (Pinto 
and Winans, 2011; Zhu et al., 2000).  By activating the transcription of the 
repABC operon, the plasmid copy number of the Ti plasmid increases and 
this enhances the expression of all Ti plasmid-encoded genes (Li and 
Farrand, 2000; Pappas and Winans, 2003b).  TraR controls the expression 
of  three different promoters involved in the regulation of the repABC 
operon (Pappas and Winans, 2003a). repAP1 is a class II promoter 
divergent from the  traI-trb promoter and controlled by tra box II (Fuqua and 
Winans, 1996a; Pappas and Winans, 2003b). The tra box II is also used for 
the activation of a class I promoter, repAP2, where the tra box lies -65.5 
nucleotides from the transcription start site. The activation of the third 
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promoter of the repABC operon, repAP3, is through the binding of TraR to 
tra box III and this is a class II promoter. 
 traM: the expression of traM occurs from tra box IV, which is located -65.5 
nucleotides from the transcription start site, and is a class I promoter. TraM 
is an antiactivator protein which inactivates TraR.  This protein is the focus 
of the next section and also of Chapter 4. 
The mechanism of transcription activation involves the binding of TraR-
OOHL to the tra boxes and recruiting RNA polymerase to adjacent promoters.  
Extensive mutagenesis studies in the N-terminal domain (NTD) and carboxy-
terminal domain (CTD) of TraR has revealed surfaces that are important for 
transcription activation, and which are thought to make direct contact with this 
enzyme (Costa et al., 2009; Luo and Farrand, 1999; Luo et al., 2003; Qin et 
al., 2004; Qin et al., 2009; White and Winans, 2005).  
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Figure 1.6. Transcription regulation by TraR on the octopine-type Ti plasmid. 
The TraR regulated genes are shown in the black rectangles and the specific 
sequences of DNA recognized by TraR are show in red and are indicated as 
tra boxes I, II, III and IV. The bold bars represent the -10 and -35 regions 
recognized by the RNA polymerase. The start sites of the transcription are 
indicated by arrows and the promoter name is indicated at the top of the 
arrow.   
 
 
 
 
 
 
 
 
traM
traAFBHyci-traGDC
trb-traI repABC
tra box I
tra box II
tra box IV
TraR
PtraM
PrepAP2
PtraI-trb
PtraCDG-yci PtraAFBH
PrepAP1
tra box III
PrepAP3
22 
1.5. TraR regulation  
The levels of TraR are tightly regulated at transcriptional and post-
translational levels.  At a transcription level, TraR is the last gene of the 
operon regulated by OccR.  As described above, OccR is a LysR-type 
transcription factor that detects octopine (Akakura and Winans, 2002; Fuqua 
and Winans, 1996b; Habeeb et al., 1991; von Lintig et al., 1991). 
Consequently, OccR is only active in the plant tumor environment, where 
octopine is abundant.  After being transcribed, TraR levels are closely 
regulated at the post-transcriptional level by the signal molecule OOHL and  
by the antiactivators TrlR and TraM (Chai et al., 2001; Chen et al., 2007; Zhu 
and Winans, 1999, 2001). 
1.5.1. OOHL 
TraR activity requires OOHL, which accumulates only at high bacterial 
density. OOHL is completely buried in a pocket located in the TraR-NTD 
(Zhang et al., 2002).  The interactions between TraR and OOHL involve both 
hydrogen bonds and hydrophobic interactions (Chai and Winans, 2004).  
Structural studies of TraR and experimental studies with whole cells suggest 
that OOHL is used as a scaffold for TraR folding.  Biochemical analysis of the 
protein showed that when TraR is produced in the bacterial cells in the 
absence of OOHL (apo-TraR), it is degraded rapidly.  Clp and Lon proteases 
both participate in the degradation of apo-TraR (Zhu and Winans, 2001).  
Differently from LuxR, which has a reversible binding to its signal molecule 
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(Urbanowski et al., 2004), binding of TraR to OOHL is irreversible, with a low 
dissociation constant and a high affinity (Zhu and Winans, 2001). It is believed 
that TraR folds in a co-translational manner based on the facts that binding to 
OOHL is irreversible and that the resistance to protease degradation do not 
change with the addition of exogenous OOHL (Zhu and Winans, 1999, 2001). 
This is a further indication that OOHL is critical for folding, stability and 
functionality of TraR. 
1.5.2. TraR dimerization 
Dimerization also plays a role in the stability of TraR, increasing its 
resistance to proteolysis (Pinto and Winans, 2009). Both the CTD and NTD 
domains of TraR are involved in dimerization (Pinto and Winans, 2009; Qin et 
al., 2000; Zhu and Winans, 2001). The NTD contributes more extensively than 
the CTD in this process. In the NTD, dimerization occurs between a long 
alpha-helix (α-9) in one subunit of TraR that forms a parallel coiled coil with 
the same helix of the opposite subunit (Vannini et al., 2002; Zhang et al., 
2002). The amino acid residues necessary for dimerization were mapped 
using x-ray crystallography and mutations in these amino acids showed 
increased instability, (Pinto and Winans, 2009; Zhang et al., 2002).  The 
dimerization helices can be viewed in Figure 1.5 and an illustration of TraR 
proteolysis is shown in Figure 1.7.  However, even the dimerized TraR is 
degraded at a detectable rate (Zhu and Winans, 1999). 
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Figure 1.7. Illustration of TraR proteolysis. Apo-TraR is degraded faster than 
TraR-OOHL. TraR-OOHL monomers are more stable than Apo-TraR, but less 
stable than TraR-OOHL dimers. Even after dimerization, when TraR is active 
and can bind to DNA, TraR is degraded at a detectable level. As thicker are 
the arrows, as faster degradation of TraR occurs.   Adapted from Pinto et al., 
2009. 
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1.5.3. Antiactivation of TraR 
TraR has two antiactivators, TrlR and TraM, which are encoded by the 
octopine-type Ti plasmid and inactivate TraR by binding to it (Chai et al., 2001; 
Chen et al., 2004; Chen et al., 2007; Vannini et al., 2004). This controls the 
levels of active TraR in the cells. 
TrlR 
TrlR is part of the mannopine catabolism operon, which is controlled by 
mannopine, an opine that is composed of mannose conjugated to glutamine, 
and unrelated to octopine.  TrlR is only found in the octopine-type Ti plasmid.  
Mannopine was found to inhibit conjugation of the Ti plasmid and this inhibition 
was dependent on the presence of TrlR (Oger et al., 1998; Zhu and Winans, 
1998). When TrlR was expressed from a constitutive promoter, it resulted in a 
decrease of conjugation, indicating that TrlR had a negative effect in the 
process (Chai et al., 2001).   
TrlR is 88% identical to TraR but is truncated and lacks a DNA binding 
domain, due to a frame shift mutation.  Site-directed mutagenesis was used to 
restore the reading frame of full length gene, resulting in a fully active protein 
(Zhu and Winans, 1998).  TrlR also binds OOHL and it is able to form inactive 
heterodimers with TraR. These heterodimers do not stably bind DNA (Chai et 
al., 2001). This effectively inactivates the TraR. 
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TraM 
TraM is an 11 KDa protein that does not have similarity with any other 
known protein (Hwang et al., 1995; Vannini et al., 2004). The crystal structure 
of TraM was published in 2004 (Chen et al., 2004; Vannini et al., 2004) and 
the structure of  co-crystals of TraM and TraR was published in 2007 (Figure 
1.8) (Chen et al., 2007). TraM binds mainly to helix10 and helix 11 of TraR 
CTD.  The TraM binding forces the two CTDs of TraR apart so they can no 
longer bind to tra box sequences (Chen et al., 2007).  In fact, biochemical and 
genetic studies have identified the amino acids of TraM that interact with TraR 
and vice-versa confirming the structural model (Qin et al., 2007). It was also 
shown that a null mutation in TraM causes hyperconjugation and lower 
concentrations of OOHL are required for the TraR-dependent gene activation. 
On the other hand, the overexpression of TraM causes the opposite effect 
(Fuqua et al., 1995; Hwang et al., 1995). Other studies show that the anti-
activation effects of TraM occur through the contact between the antiactivator 
and TraR-OOHL (Hwang et al., 1999; Swiderska et al., 2001)  An interesting 
observation is that in both nopaline and octopine type Ti plasmids, TraR-
OOHL activates the transcription of traM, providing a negative feedback loop 
(Fuqua et al., 1995; Hwang et al., 1995). Interestingly, TraR is not the only 
protein that seems to regulate TraM. In fact, phospho-VirG was found to 
induce the expression of TraM (Cho and Winans, 2005). As discussed before, 
phospho-VirG activates the expression of the vir operon which is responsible 
for the processing and transfering of the T-DNA to the plant host. The 
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expression of TraM by phospho-virG is perhaps important to avoid 
simultaneous expression of the vir and tra system because both produce type 
IV secretion systems to transfer DNA and they might interfere with each other. 
This also makes sure that plant transformation occurs before bacterial 
conjugation (Cho and Winans, 2005). The fate of the proteins after the 
antiactivator binds to TraR is one of the topics examined in detail in this 
dissertation (Chapter 4). 
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Figure 1.8. Interactions between TraM and TraR. A) Model of co-crystal 
between dimer TraM, shown in blue and dimer TraR, shown in red. B) TraM 
side chains are shown in cyan and the helices in  blue. TraR helices that 
contact TraM are shown in red and the side chains in magenta. The 
interactions between residue W186 of TraR and TraM are shown where the 
oxygen atom can be seen in red and the nitrogen atoms in blue. C) The 
interactions between residue L199 of TraR and a hydrophobic cluster at the 
CTD of TraM. The hydrophobic side chains are shown in gray and the 
residues that directly contact L199 in cyan (Chen et al., 2007). 
A
CB
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1.6. Contents of the dissertation 
TraR is the predominant focus of this dissertation. In Chapter 2, site-
directed mutagenesis studies are carried out in order to identify the amino 
acids in the NTD of TraR that are critical for the interaction between TraR and 
the RNA polymerase. These studies allow the identification of patches of 
amino acids on the surface of TraR that mediate the interaction.  This allows a 
better understanding of how transcription activation occurs at a molecular 
level. 
Chapter 3 deals with the susceptibility of TraR to proteolysis. TraR 
abundance is subject to a number of factors, including transcription of the traR 
gene in response to octopine, and by proteolytic degradation.  Apo-TraR is 
rapidly destroyed, and TraR-OOHL complexes that fail to dimerize are also 
degraded.  Even dimeric TraR is still subject to proteolysis. In Chapter 3, I 
examine the proteolysis of TraR in detail: in particular, I investigate which 
regions of TraR provide targets for cellular proteases. Two recognition motifs 
in the CTD of TraR were found.  Mutation studies revealed that the protein 
was more stable when these regions were mutated or when the regions were 
removed. 
In Chapter 4 I consider the antiactivator protein of TraR, TraM. As 
discussed above (Section 1.5), it is known that TraM inactivates TraR by 
forming a 2:2 complex. The particular focus of my study is to examine the fate 
of these complexes.  The results indicate that TraR in these complexes is 
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targeted for proteolysis, while TraM in the same complexes is spared from 
proteolysis, and can act catalytically to cause degradation of additional TraR 
dimers. 
 Chapter 5 contains the conclusions and a discussion of future 
directions.  
Appendix 1 considers a different transcription activator from the LuxR 
family, CepR.  This transcription activator is found in Burkholderia 
cenocepacia, an opportunistic human pathogen.  My contribution to this 
collaborative work was to mutagenize a CepR binding site, in order to identify 
bases that are required for CepR binding.  Others in this project used this 
information to define a consensus CepR binding site and to identify new 
CepR-regulated promoters.  
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1CHAPTER 2 
 
Identification of Amino Acid Residues of the Pheromone-binding Domain 
of the Transcription Factor TraR that are Required for Positive Control 
 
2.1. Summary 
Genes required for replication and for conjugal transfer of the 
Agrobacterium tumefaciens Ti plasmid are regulated by the quorum sensing 
transcription factor TraR, whose N-terminal domain binds to the pheromone 
N-3-oxooctanoyl-L-homoserine lactone (OOHL) and whose C-terminal domain 
binds to specific DNA sequences called tra boxes. Here, we constructed 117 
mutants, altering 103 surface-exposed amino acid residues of the TraR 
N-terminal domain. Each mutant was tested for activation of the traI promoter, 
where TraR binds to a site centered 45 nucleotides upstream of the 
transcription start site, and of the traM promoter, where TraR binds a site 
centered 66 nucleotides upstream. Alteration of 18 residues blocked activity at 
the traI promoter.  Of these, alteration at three positions impaired TraR 
abundance or DNA binding, leaving 15 residues that are specifically needed 
for positive control. Of these 15 residues, nine also blocked or reduced activity 
at the traM promoter, while six had no effect. Amino acid residues required for  
1 
Costa, E.D., Cho, H., and Winans, S.C. (2009) Identification of amino acid residues of the 
pheromone-binding domain of the transcription factor TraR that are required for positive 
control. Mol Microbiol 73(3): 341-351. Table 2.4 and Fig. 2.4 were done by Cho, H. All the 
other figures and Tables were done by Costa, E.D. 
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activation of both promoters probably contact the carboxy terminal domain of 
the RNA polymerase α subunit, while residues required only for traI promoter 
activation may contact another RNA polymerase component. 
 
2.2. Introduction 
Many species of bacteria use diffusible pheromones to coordinate a 
wide range of physiology, including pathogenesis, sporulation, the formation of 
biofilms, and horizontal transfer of DNA (Whitehead et al., 2001; Winans and 
Bassler, 2002). One such regulatory system is composed of the LuxI and 
LuxR proteins of Vibrio fischeri, where LuxI synthesizes 3-oxo-
hexanoylhomoserine lactone (OHHL) (Eberhard et al., 1981), while LuxR is an 
OHHL receptor and OHHL-dependent transcription factor of the organism's 
bioluminescence operon. In the past 15 years, a wide variety of related 
systems have been discovered, and a small number of them have been 
intensively studied. In most cases, a LuxI homolog is functionally paired with a 
LuxR homolog, in that the former synthesizes an acylhomoserine lactone 
(AHL) while the latter is a transcription factor that binds the cognate AHL. In 
most cases, DNA binding activity requires the AHL (Pappas et al., 2004), while 
in a few cases, the AHL has the opposite effect, blocking DNA binding 
(Castang et al., 2006; Cui et al., 2006; Fineran et al., 2005; Sjoblom et al., 
2006). Biochemical, genetic, and structural studies of a number of LuxR 
homologues have revealed that they are two-domain proteins, whose N-
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terminal domain (NTD) binds AHLs and whose C-terminal domain (CTD) binds 
DNA (Pappas et al.,2004). Both domains contribute to protein dimerization 
(Luo et al., 2003; Vannini et al., 2002; Zhang et al., 2002).   
The Ti plasmid of the plant pathogen Agrobacterium tumefaciens 
encodes such a regulatory system, consisting of the AHL synthase TraI and 
the transcription factor TraR.  TraI synthesizes primarily 3-oxo-
octanoylhomoserine lactone (OOHL) while TraR is an OOHL-dependent 
activator of three closely spaced promoters of the repABC operon, which 
directs plasmid replication and partitioning, and of three promoters of the 
tra and trb operons, which are required for conjugative transfer of the Ti 
plasmid (Piper et al., 1993; Zhang et al., 1993; Fuqua and Winans, 1994; More 
et al., 1996; Li and Farrand, 2000; Pappas and Winans, 2003). TraR-OOHL 
complexes bind to 18-nucleotide dyad-symmetrical sequences called tra 
boxes to activate transcription of target promoters (Winans et al., 1999).  
Genetic, biochemical and structural studies of TraR and its interactions 
with OOHL and DNA have made this protein an intensively studied 
representative of the LuxR family. TraR monomers bind to OOHL in a 1:1 mole 
ratio and form homodimers that bind to tra boxes with high affinity and 
specificity (Luo and Farrand, 1999; Zhu and Winans, 1999). The N-terminal 
pheromone-binding domain of TraR is sufficient for OOHL binding and 
dimerization, as TraR fragments containing just this domain are able to form 
inactive heterodimers with full-length protein (Chai et al., 2001; Luo et al., 
2003; Qin et al., 2000; Zhu and Winans, 1998). Binding of OOHL to TraR is 
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virtually irreversible, as this pheromone is buried deeply within the protein and 
makes no contact with bulk solvent. Activity of TraR, LuxR, and a few other 
members of this family have been reconstituted in vitro, and require only 
promoter DNA, the activator complexed with its AHL, and RNA polymerase 
(RNAP) (urbanowski et al., 2004; Zhu and Winans, 1999).  
The quaternary structure of TraR, OOHL, and tra box DNA has been 
solved by X-ray crystallography (Vannini et al., 2002; Zhang et al., 2002). This 
structure confirmed the domain structure of this dimeric protein. Protein 
dimerization is achieved largely by a rather long alpha helix on each of the two 
the N terminal domains, which together create a coiled coil, and by two shorter 
helices in the C terminal domains (CTD), which create a second coiled coil. 
The CTD is a four-helix bundle with a helix-turn-helix DNA binding motif (HTH) 
common to many prokaryotic regulators (Nelson, 1995). This four-helix domain 
structure is common to all members of the LuxR-NarL-FixJ superfamily of 
prokaryotic transcriptional regulators (Fuqua and Greenberg, 2002). Several 
amino acid residues found on the recognition helix make specific contact with 
tra box DNA sequences 
(Vannini et al., 2002; White and Winans, 2007; Zhang et al., 2002).   
There are seven known TraR-dependent promoters on the 
octopine-type Ti plasmid, all of which contain tra boxes. At five of these 
promoters (PtraA, PtraC, PtraI, PrepA1, and PrepA3) the TraR-binding site is 
centered approximately 45 nucleotides upstream of the transcription start site, 
adjacent to the -35 elements of these promoters.  At the remaining two 
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promoters (PrepA2 and PtraM), the tra box is located approximately 66 
nucleotides upstream.   
The first class of promoters are reminiscent of class II-type promoters 
first described for CAP (Busby and Ebright, 1999) while the second class of 
promoters resemble class I-type promoters. Activators of class II-type 
promoters can interact with several different subunits of RNAP, while 
activators of class I-type promoters are generally thought to interact with the 
C-terminal domain of the alpha subunit of RNAP (α-CTD), which is connected 
to α-NTD by a flexible linker (Busby and Ebright, 1999). A number of other 
activators have been shown to contact either the α or σ subunits via their DNA 
binding domains (Busby and Ebright, 1999; Bushman et al., 1989; Crater and 
Moran, 2002; Danot et al., 1996; Stibitz, 1994). 
In a previous study (White and Winans, 2005), we used TraR structural 
data to alter all surface exposed amino acids of the C-terminal domain, and 
tested each for defects in activating a class I promoter and a class II promoter 
(White and Winans, 2005). Alteration of six amino acid residues abolished 
activation of both promoters, without significantly affecting protein 
accumulation or DNA binding.  As these mutants were defective at both 
classes of promoter, we concluded that the residues of the wild type TraR 
most likely interacted with the α CTD. 
Two residues in the N-terminal domain of the pTiC58 TraR protein are 
critical for activation of a class II type promoter (Luo and Farrand, 1999). 
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Mutations of these residues (D10 and G123) disrupted contacts with purified 
α-CTD (Qin et al., 2004).  It seemed plausible that other residues in the N-
terminal domain of TraR might also make specific contacts with RNAP. In 
order to study the role of the TraR N-terminal domain in transcription 
activation, we performed saturating site-directed mutagenesis of all 
surface-exposed TraR residues. Each mutant was tested for in vivo activity at 
a class II promoter, for its accumulation in vivo, and for ability to bind DNA in 
vitro. We identified 15 mutations that accumulate and bind to DNA but that fail 
to activate the class II promoter. Of these, 9 mutants also abolish activation of 
the class I promoter, while the remaining 6 mutants affected only the class II 
promoter. From these data, and from the positions of these mutations on the 
surface of TraR, we speculate that the residues needed for both class I and 
class II promoters are likely to interact with α CTD of RNAP, while the residues 
needed only for the class II promoter are likely to interact with another RNAP 
subunit. 
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2.3. Results 
Mutagenesis of residues in the N-terminal domain of TraR 
As described above, we sought to determine whether the N-terminal 
domain of TraR contains regions likely to make direct contact with RNA 
polymerase. We used the X-ray crystal structure of TraR 
(Vannini et al., 2002; Zhang et al., 2002) to identify all solvent-exposed 
residues on this part of the protein, and used site-directed mutagenesis to alter 
each residue (Vannini et al., 2002; Zhang et al., 2002). Seven residues of the 
linker domain were also included in this study. We have previously found that 
many alterations of surface residues of TraR can cause a significant decrease 
in protein accumulation, indicating that the mutants were sensitive to 
proteolysis (White and Winans, 2005). In an effort to minimize this problem, 
we made substitutions wherever possible that preserved interactions with 
adjacent amino acid residues, but that altered the surface exposed to solvent. 
In all, 117 point mutants were constructed at 103 positions, saturating the 
surface of the TraR NTD. These mutants are listed in Table S1 and also 
indicated in Fig. 2.1. 
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Figure 2.1. Saturation mutagenesis of the surface of the NTD of TraR.  
Residues in white were altered by site-directed mutagenesis.  
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Activity of TraR mutants in vivo 
Each TraR mutant was tested for its ability to activate transcription of a 
TraR-dependent promoter. We used A. tumefaciens strain NTL4 (pCEW260), 
which lacks a Ti plasmid and thus does not have the native traR or traI genes 
(Luo et al., 2001). Plasmid pCW260 contains a PtraI-lacZ fusion, and has a 
wild type traI promoter except for a one-nucleotide mutation in its tra box. This 
mutation creates a consensus tra box with perfect dyad symmetry 
(White and Winans, 2005). The wild type TraR protein expressed this fusion at 
high levels (approximately 3000 Miller units) in the presence of saturating 
levels of OOHL (100 nM), while its activity in the absence of either TraR or 
OOHL was barely detectable (less than 5 Miller units). OOHL was added at 
four different concentrations (0.1 nM, 1 nM, 10 nM and 100 nM) to each 
culture and assayed for β-galactosidase activity 8 hours later. The resulting 
expression levels for all 117 mutants are shown in Table S1. Twenty mutants, 
together altering 18 residues, showed less than 50% of wild type activity in the 
presence of 100 nM OOHL (Table 2.1). 
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Table 2.1.  Mutations in the TraR N Terminal Domain that are defective in 
transcriptiona 
 
a: All mutations included in this list functioned at levels 50% or lower than wild 
type TraR in the presence of 100 nM OOHL.  Data are presented as a 
percentage of wild type.   
b: Wild type TraR expressed the promoter, a traI-lacZ fusion, at 700, 1500, 
2600 and 3000 units of β-galactosidase activity at 0.1 nM, 1 nM, 10 nM 
and 100 nM of OOHL, respectively. 
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In vivo accumulation of mutant proteins 
In previous studies, we found that some TraR point mutants defective in 
activation also failed to accumulate in vivo (White and Winans, 2005). We 
therefore used semi-quantitative Western immunoblotting to test all mutants 
for their ability to accumulate in vivo. These assays were done using the same 
A. tumefaciens strain as used for activity assays described above. Equivalent 
amounts of crude cell extracts were loaded into each lane. A representative 
Western is shown in Fig. 2.2, and the data expressed in per cent accumulation 
compared with wild type for all mutants are summarized in Table S1. Results 
for the 20 mutants described above are shown in Table 2.2. 
Of the 20 mutants described in Table 2.1, three mutants accumulated at 
levels less than 45% of wild type (Table 2.2). Conversely, 17 mutations, 
altering 16 different residues, did not cause a decrease in abundance 
commensurate with their decrease in activity. These 16 mutations are 
expected to cause defects in some other aspect of transcription activation, 
possibly either DNA binding or interactions with RNAP.   
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Figure 2.2.  Western immunoblot data of TraR point mutants in A. tumefaciens 
strain NTL4 (pCEW260). Strains containing pYC335 or pPZP201served as 
positive and negative controls, respectively. Purified TraR was also used as a 
positive control for all westerns (left lane). The cross-reacting material (CRM) 
was used to normalize the intensity of each TraR band. 
 
 
 
 
 
 
 
 
TraR
CRM
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Table 2.2.  Accumulation in A. tumefaciens and DNA-binding affinity in vitro of 
all transcription-defective mutants. 
 
a: NT, not determined. 
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Ability of TraR mutants to bind DNA fragments containing tra box 
sequences 
We conducted electrophoretic mobility shift assays (EMSA) using a 
radiolabeled DNA fragment and cleared cell lysates containing TraR point 
mutants. The strains were cultured in the presence of OOHL and Western 
blots were performed with each cleared cell lysate (data not shown). The 
volumes of each lysate added to the gel were adjusted using the Western 
immunoblot data described above. The DNA fragment used in these 
experiments contained the traA-traC intergenic region, which contains a 
consensus binding site for TraR. Mutants that had severe defects in 
accumulation in A. tumefaciens (see above) also did not accumulate well in 
the protease-deficient strain KY2347, and were therefore not included in the 
gel mobility shift assays. Representative EMSA data are shown in Fig. 2.3, 
while the data for all mutants are summarized in Table S1.  Complexes were 
not detected using an extract lacking TraR (Fig. 2.3, lanes labeled vector 
control). Of the 20 transcription-defective mutants described in Table 2.1, 
three bound the tra box DNA fragment at levels less than 40% of wild type 
(Table 2.2). For these mutants, D17E, H44K, and N122D, the defect in DNA 
binding could explain the defect in transcription. However, two of these 
mutants were also defective in accumulation.  In all, a total of 16 mutants, 
altering 15 residues, showed defects in transcription that could not be 
accounted for by a lack of accumulation or an inability to bind tra box DNA. 
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These mutants are therefore candidates for having defects in interactions with 
RNA polymerase.  
 
 
 
Figure 2.3.  Electrophoretic mobility shift assays with TraR in crude cell 
extracts. The amount of full-length, soluble TraR in each extract was 
normalized using western immunoblots.  
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Table 2.3.  Activity of TraR mutants at the TraM promoter. 
 
 
 
 
 
 
 
 57 
Activity of site-directed mutants at a class I promoter 
The activity assays described above were all done with a class II 
promoter, where TraR could interact with several different subunits of RNAP. 
We also tested these mutants at the traM promoter, which is a class I 
promoter. TraR activating such a promoter should in principle interact only with 
α CTD. The promoter we used was identical to the wild type PtraM promoter 
except that its tra box contained the consensus TraR binding sequence 
(White and Winans, 2005).  
This promoter has a TraR-independent basal expression of 
approximately 120 Miller units, and is activated only approximately seven-fold 
by TraR in the presence of saturating OOHL concentrations. Since this 
induction ratio is rather low, we tested the mutants using saturating levels of 
OOHL (100 nM) and deducted the TraR-independent activity of this promoter. 
Many of the TraR mutants that were impaired at traI were also impaired at 
PtraM (Table 2.3). The clearest examples of this include D6G, D10N, K74E, 
R77E, and G123R, while other possible examples include R75E, S78E, R79E, 
and D144R. In a previous study, additional positive control mutations were 
isolated in the TraR CTD, all of which blocked activity at both types of 
promoters (White and Winans, 2005). 
A few of the mutants that were defective at the traI promoter were 
unimpaired at the PtraM promoter (Table 2.3). The clearest examples of this 
are A13L, I20W, and K80E, while other possible examples include K7R, E15K, 
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and N122A. These phenotypes suggest that the wild type residues at these 
positions contact RNAP at the traI promoter but make no critical contacts with 
RNAP at the traM promoter.   
Intragenic complementation of TraR mutants 
Dimeric transcription factors ought in principle to have two activating 
regions (ARs) per dimer. If an AR is composed of amino acids from both 
subunits, it may be possible to restore protein function by co-expressing two 
defective proteins (see Fig. 2.4). The data described above, taken in 
conjunction with structural information, suggested that the AR that contacts α-
CTD might be composed of amino acid residues of both TraR subunits. To test 
this, we co-expressed various TraR PC mutants and assayed for TraI 
promoter activity. One of these mutations, W184H, lies in the TraR-CTD and 
has a strong positive control defect (White and Winans, 2005). When mutant 
D10N was co-expressed with W184H, no complementation was observed 
(Table 2.4). This suggests that one mutation disrupted one of the two ARs in 
the TraR dimer, while the other mutation disrupted the second AR (Fig. 2.4). 
W184 and D10 of each AR must therefore be contributed by the same subunit. 
In contrast, when mutants G123R and W184H were co-expressed, activity 
was almost fully restored (Table 2.4). This suggests that W184 and G123 of 
each AR are contributed by different subunits, and that in the merodiploid 
strain, each heterodimer has one functional site and one doubly non-functional 
one (Fig. 2.4).   
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Table 2.4.  Intragenic complementation of positive control mutations of TraR.   
 
 
 
Figure 2.4.  Intragenic complementation of mutations of D10, G123, and 
W184. Successful complementation was taken as an indication that the amino 
acid residues are contributed by opposite subunits. 
 
In a third experiment, mutants D10N and G123R were co-expressed. 
Activity was restored, but not to wild type levels (Table 2.3). The restoration of 
activity suggests that D10 and G123 of each AR are contributed by different 
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subunits. The fact that restoration was incomplete suggests that the two 
mutations on one AR somehow weakened the activity of the opposite AR, 
possibly via a perturbation of the quaternary structure of the TraR dimer.  
 
2.4. Discussion 
In a previous study, we saturated the surface of the TraR CTD with 
point mutations, and identified a contiguous patch of residues that are 
essential for activation of Class I and Class II promoters 
(White and Winans, 2005). In the present study, we sought to identify one or 
more similar patches on the TraR NTD. Two positive control mutations in the 
TraR NTD have previously been described by another group (Qin et al., 2004). 
Saturation mutagenesis of the surface of the TraR NTD led to the discovery of 
a significant number of residues that are required for positive control. Each 
such residue may make direct contacts with RNAP.   
TraR is probably a highly flexible molecule, with two NTDs tethered to 
two CTDs by a flexible linker. If so, then the spatial position of the two NTDs of 
the dimer with respect to the two CTDs could be highly variable at different 
promoters. We believe that the CTDs of the TraR dimer, once bound to tra box 
DNA, can then recruit RNAP to the promoter. Different surfaces of the TraR 
NTDs could then “explore” the surface of any proximal RNAP surface until a 
patch of TraR binds a patch of RNAP.   
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Assuming that residues required for positive control do contact RNAP, 
we would like to begin to map these interactions, identifying which subunit of 
RNAP is contacted by each residue. Presumably, residues required for 
activation of both class I and class II promoters most likely contact the α-CTD, 
while residues required only for class II promoters are more likely to contact 
some other RNAP subunit. We have divided all positive control mutants into 
two groups: (i) those that affect the Class I and Class II promoters, and (ii) 
those that affect only the Class II promoter. Residues of the former class are 
likely to contact α-CTD and are shown in white in Figures 2.5 and 2.6, while 
the latter class are likely to contact another RNAP subunit and are shown in 
black.   
The asymmetry of crystallized TraR creates what we will refer to as a 
“concave” surface and a “convex” surface (Fig. 2.5). In many cases, residues 
that are quite closely packed on the concave surface are widely dispersed on 
the convex surface. For example, W184 of one subunit and G123 of the other 
subunit lie less than 5 angstroms apart on the concave surface, but lie 55 
angstroms apart on the convex surface. All the amino acid residues that are 
thought to contact α-CTD are closely spaced on the concave surface, while 
they are widely separated on the convex surface. As a working model, we 
propose that the asymmetry of cyrstalized TraR resembles to some degree the 
active form in vivo, and that the concave surface of TraR resembles the 
surface that contacts α-CTD. If so, all four domains of the TraR dimer 
contribute residues to this putative patch. Three are contributed by the NTD of 
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the A subunit (D6, D10 and D144), six are contributed by the NTD of the B 
subunit (K74, R75, R77, S78, R79, and G123), five are contributed by the CTD 
of the A subunit (W184, V187, K189, E193 and V197), and one is contributed 
by the CTD of the B subunit (D217). Some of these residues are somewhat 
sheltered from solvent, especially D6, D10, but would be far more exposed to 
solvent if the NTD and CTD were to separate slightly. Intragenic 
complementation analysis supports this model, as it demonstrated that 
residues G123 and D10 are contributed by opposite subunits, as are residues 
G123 and W184, while W184 and D10 are contributed by the same subunit.   
Of the fifteen residues of this patch, five are basic and five are acidic. 
As described above, these residues most likely interact with α-CTD of RNAP. 
Given the flexibility of the TraR linker, the NTD and CTD of this protein should 
be able to separate, so that the residues contributed by the two CTDs could 
bind one face of α-CTD of RNAP, while the residues contributed by the two 
NTDs could bind another face. The α-CTD of RNAP of A. tumefaciens has a 
pronounced acidic patch that could conceivably bind the basic residues K74, 
R75, R77, and R79 (data not shown). 
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Figure 2.5.  Positive control mutants isolated in this study (in the TraR NTD) 
and in a previous study (TraR-CTD) (White and Winans, 2005). Residues in 
white affect both PtraI and PtraM, while residues in black affected only PtraI. 
(A) View of TraR along the DNA axis, showing the concave and convex faces 
of the crystal structure. (B and C) TraR rotated to show the concave surface 
and convex surfaces, respectively.   
 
Four residues (W184, V187, K189, and V197) are located at or near the 
turn between α-helix 10 and α-helix 11 (the scaffold helix of the helix-turn-helix 
motif). Very similar activating regions have been identified in a number of other 
regulators with HTH motifs, including CAP, FNR, SoxS, and 8C1 (Bell and 
Busby, 1994; Busby and Ebright, 1999; Bushman et al., 1989; Griffith and 
Wolf, 2002). In all of these cases, the activating region includes a 
surface-exposed loop similar to that of TraR.  Similar ARs have been identified 
in the DNA-binding domains of the NarL homologues GerE and BvgA 
(Crater and Moran, 2002; Stibitz, 1994). The activating region of FNR that 
contacts α-CTD is also extensive and spans across three surface-exposed 
loops, while the FNR homologue CAP contacts the α-CTD with just one loop 
(Bell and Busby, 1994; Busby and Ebright, 1999; Li et al., 1998; Williams et 
al., 1997).   . 
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Although we predict that the two activating regions described above 
contact the α-CTD, the positions of these patches are intriguing. In the 
CAP-αCTD-DNA ternary structure, the α-CTD binds in the minor groove 
directly downstream of CAP in class I promoters, and directly upstream of 
CAP in class II promoters. Contacts are therefore made using the 
“downstream surface” or “upstream surface” of CAP, respectively. In contrast, 
the activating regions of TraR lie neither on the upstream nor downstream 
surfaces of the protein, but rather on a side surface, suggesting that α-CTD 
could bind DNA to one side of TraR (Fig. 2.5B). This was reported to be the 
case for the BvgA protein of Bordetella pertussis (Boucher et al., 2003).  
Some of the positive control mutants isolated in this study affected only 
the Class II promoter (indicated in black in Figures 2.5 and 2.6). The simplest 
interpretation is that all or at least most of these mutations block interactions 
between TraR and a portion of RNAP other than α-CTD. One problem with 
this interpretation is that some of these mutants overlap regions that were 
interpreted as binding α-CTD. For example, the mutation K80E blocked PtraI 
expression, but had no effect on PtraM (Table 2.3). However, residue K80 is 
adjacent to residues K74-R79, which were needed for both promoters. 
Similarly, residues K7, A13, E15, I20 of one subunit, and N122 from the other 
subunit, are needed only for PtraI, yet they roughly encircle residues D10 and 
D6, which are needed for both promoters. Nevertheless, it is tempting to 
speculate that K7, A13, E15, I20, and N122 form a contiguous patch on the 
convex surface of the TraR dimer, and that this patch contacts RNAP. If so, 
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alteration of D6 or of D10 might conceivably cause a more general loss of 
function of the protein, blocking activity at both promoters. 
 
 
Figure 2.6.  Closeup views of TraR residues required for positive control. 
Residues in white are needed for both promoters, while residues in black are 
needed only for PtraI. (A) A patch on the concave surface, composed of 
residues from both subunits and both domains of each subunit. (B) A patch on 
the convex surface, composed of residues from the NTDs of both subunits.   
 
The mutations that affect both promoters may be somewhat analogous 
to the AR1 region of the CAP protein of E. coli (Busby and Ebright, 1999; 
Lawson et al., 2004; Niu et al., 1996). AR1 (residues 156-164 and R209) of 
CAP interacts with the “287 determinant” of α (residues 283-288 and 314-317, 
all lying within the αCTD). In contrast, TraR residues that contact α-CTD are 
thought to lie on both the TraR CTD and the TraR NTD. AR2 of CAP (residues 
19, 21, 96, and 101, which form a contiguous patch) interacts with residues 
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162-165 of α (within the αNTD). AR3 of CAP (residues 52-58) interacts with 
residues 593-603 of α (lying within region 4, which also decodes the -35 
promoter element). At Class I promoters, only AR1 contacts RNAP, while at 
Class II promoters, AR1, AR2 and AR3 can all make productive contacts. AR1 
of CAP acts by recruiting RNA polymerase to promoters, while AR2 and AR3 
are thought to function by a combination of recruitment and postrecruitment 
mechanisms such as promoter melting.  
The LuxR CTD has been extensively mutagenized in a search of 
positive control mutants 
(Egland and Greenberg, 2001; Trott and Stevens, 2001). Three residues 
essential for activation but not for DNA binding were described, K198, W201, 
and I206, which align with residues K189, E192, and V197 of TraR, 
respectively.  K189, E193, and V197 of TraR are essential for positive control, 
indicating that these positive control regions overlap. The LuxR-NTD has not 
so far been studied at this level.  The fact that LuxR functions in E. coli has 
been exploited by using libraries of alanine scanning mutants of the RNAP α 
and σ subunits. Mutations of σ residues 591, 595, 597, 602, and 603 strongly 
inhibited LuxR-dependent gene expression (Johnson et al., 2003). Many of 
these residues were also critical in interactions between σ and AR3 of CAP 
(Lawson et al., 2004). In a separate study, alteration of α-CTD residues 262, 
265, 290, 295, 296 and 314 inhibited LuxR activity. These residues overlap 
the 287 determinant, which interacts with AR1 of CAP (Lawson et al., 2004). 
These studies using screening of alanine-scanning mutants of LuxR or RNAP 
 67 
subunits thus provided evidence that LuxR binds both the α-CTD and σ 
subunits of the RNAP (Finney et al., 2002; Johnson et al., 2003; Stevens et 
al., 1999).   
 
2.5. Experimental Procedures 
Bacterial strains and plasmids 
Bacterial strains and plasmids used in this study are listed in Table 2.5. 
A. tumefaciens strains were cultured in AT minimal medium at 28°C 
(Tempe et al., 1977). Escherichia coli strains were cultured in LB medium. 
Synthetic OOHL was provided by A. Eberhard (Cornell University). Antibiotics 
were added to maintain plasmids at the following concentrations: 100 µg/mL 
spectinomycin, and 50 µg/mL kanamycin for E. coli; and 200 µg/mL 
spectinomycin and 200 µg/mL kanamycin for A. tumefaciens. 
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Table 2.5.  Strains and plasmids used in this study. 
 
DNA manipulations and strain constructions 
Recombinant DNA techniques were performed using standard 
procedures (Sambrook and Russell, 2001). Plasmid DNA was isolated from E. 
coli with QIAprep spin miniprep kits (Qiagen) for DNA sequence analysis. DNA 
sequences of constructs that were obtained by PCR were verified using 
automated DNA sequencing (Cornell Biotechnology Resource Center) and 
analyzed using the LaserGene program (DNASTAR). Plasmids were 
introduced into E. coli by transformation (Sambrook and Russell, 2001) and 
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into A. tumefaciens by electroporation (Cangelosi et al., 1991). E. coli strain 
DH5α was used for all plasmid constructions. 
Site-directed mutagenesis 
Site-directed mutagenesis of TraR was performed  using synthetic 
overlap extension PCR (Sambrook and Russell, 2001). A 978 bp fragment of 
plasmid pYC335 was amplified using Taq polymerase High Fidelity 
(Invitrogen). The restriction sites for EcoRI and SacII were used to introduce 
mutated DNA fragments into the wild type gene. For mutations T167S, A168V 
and E169Q, we used EcoRI and MfeI. All oligonucleotides used in this study 
are listed in Table S2 and were obtained from Integrated DNA Technologies 
(Coralville, Iowa). Restriction enzymes were obtained from New England 
Biolabs. 
In vivo assays for TraR activity 
Bioassays were conducted with derivatives of A. tumefaciens strain 
NTL4 harboring plasmid pCEW260, which carries PtraI-lacZ reporter or 
pCEW105, which carries a PtraM-lacZ reporter. Each strain also contained 
plasmid pYC335, which expresses Plac-traR, or a derivative of pYC335 
expressing a traR point mutant. Strains were cultured in At minimal  medium to 
an OD600 of 0.3 to 0.4. Each was then diluted 20 fold into fresh AT medium 
containing the indicated concentrations of OOHL, and incubated with vigorous 
aeration for 8 hours. Assays for β-galactosidase activity were performed as 
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previously described (Miller, 1972). All experiments were conducted in 
triplicate and repeated at least three times. 
Immunodetection of TraR 
The abundance of each TraR protein was determined in parallel with 
the activity assays described above. A portion of each culture was centrifuged 
and the cell pellets were resuspended in 5% of their original volume in 1x 
cracking buffer (125 mM Tris pH 6.8, 4% SDS, 20% glycerol, 200 mM DTT, 
0.02% bromophenol blue). Cells were disrupted by boiling for 5 min, cooling to 
-80°C and boiling for another 5 min. A fraction of each sample was 
size-fractionated using 12% SDS polyacrylamide gels, and electroblotted onto 
nitrocellulose membranes (BIORAD). The membranes were blocked using 
TBS (20 mM Tris pH 7.9, 500 mM NaCl, 0.05% Tween20) with 5% skim milk, 
and immunodetected in TBS with pre-adsorbed polyclonal anti-TraR rabbit 
antiserum (Chai and Winans, 2004). Goat anti-rabbit IgG conjugated with 
alkaline phosphatase (BIORAD) was used as the secondary antibody, and the 
membranes were stained with BCIP (5-bromo-4-chloro-3-indoyl phosphate 
p-toluidine salt) and NBT (p-nitro blue tetrazolium chloride) (BIORAD). 
Westerns were performed with fresh cell lysates for each strain at least three 
times. Data were analyzed using ImageJ (http://rsb.info.nih.gov/ij/) 
(Rasband, 2004), and normalized against cross-reacting material in each lane.  
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Gel mobility shift assays 
Clarified cell extracts were used for all gel mobility shift assays.  
Extracts were prepared from the strain KY2347 (a clp, lon mutant) carrying 
pYC335 or derivatives of it carrying each of the traR mutants. Strains were 
cultured at 28O C in LB broth supplemented with 100 ug/mL spectinomycin to 
an OD600 of 0.2, treated with 500 uM IPTG and 200 nM OOHL, and incubated 
for an additional 6 hours at 28°C. Cells were then harvested, resuspended in 
SEDG buffer (Pappas and Winans, 2003), disrupted using a French pressure 
cell (20,000 psi), and clarified by ultracentrifugation. TraR abundance in each 
extract was estimated using Western immunoblots, which were analyzed using 
ImageJ (Rasband, 2004). Equivalent amounts of soluble full-length TraR were 
added to each binding reaction. 
A 247 nucleotide fragment containing the consensus tra box sequence 
was constructed by PCR amplification, using pCEW250 as template and 
oligonucleotides Ptra-box For and Ptra-box Rev as primers (Table S2). A 
negative control fragment of 211 bp in length was PCR amplified from  
pCEW250 using the primers Pcontrol gel shift For and Pcontrol gel shift Rev 
(Table S2). Both fragments were end-labeled with [γ-32P]dATP (Pelkin Elmer) 
using T4 polynucleotide kinase (New England Biolabs) and incubated with 
protein extracts as previously described (Zhu and Winans, 1999). Reactions 
were size-fractionated in 8% polyacrylamide gels at 4O C as previously 
described (Pappas and Winans, 2003). Results were analyzed using a Storm 
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B840 PhosphorImager (Molecular Dynamics). Gel shifts were performed with 
independent clarified lysates at least twice for each strain. 
Intragenic complementation 
Bioassays were conducted with derivatives of A. tumefaciens strain 
WCF47 (Zhu et al., 1998) carrying a PtraI-lacZ fusion in the Ti plasmid. The 
TraR mutants, W184H, D10N and G123R were cloned in both pPZP201 and 
pBBR1MCS5 using the restriction sites for EcoRI and BamHI. Every possible 
mutant/plasmid combination was tested. Assays for β-galactosidase activity 
using 100 nM of OOHL were performed as previously described (Miller, 1972).  
Structural analyses 
SWISSPROT PDB Viewer (Guex and Peitsch, 1997) 
(http://www.expasy.org/spdbv/) and Protein Explorer (Martz, 2002) 
(http://proteinexplorer.org) were used to identify all surface residues of the 
TraR NTD, and to map the point mutants onto the structure of TraR. There are 
two crystal structures of TraR-OOHL-DNA complexes available from RCSB 
(http://www.rcsb.org) (accession codes are 1L3L and 1HOM). 
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2CHAPTER 3 
The DNA Dinding Domain of TraR Contains Amino Acid Residues That 
Increase Protease Susceptibility 
 
3.1. Summary 
TraR of Agrobacterium tumefaciens is a LuxR-type transcription factor 
that regulates genes required for replication and conjugation of the tumor-
inducing (Ti) plasmid. TraR binds the pheromone 3-oxo-octanoylhomoserine 
lactone (OOHL) and requires this molecule for activity and for folding into a 
soluble and protease-resistant conformation. Even after binding to OOHL, 
TraR is degraded at detectable rates. In this study we show that the N-terminal 
domain of TraR, which binds OOHL, is more resistant to degradation than the 
full length protein. Degradation requires sites found on the C-terminal DNA 
binding domain (TraRCTD). TraRCTD is extremely unstable when expressed 
alone, and destabilizes fusion proteins containing maltose binding protein or 
green fluorescent protein. When the C-terminus of GFP was fused to the N-
terminus of TraRCTD, the resulting fusion was poorly fluorescent due to 
proteolysis. We identified residues at two regions of TraR-CTD that contribute 
to protein degradation. It seems that HslVU protease is involved in the 
degradation of GFP-TraRCTD. We also performed pulse chase assays 
2
Chapter 3 is a manuscript prepared for submission. Costa, E.D., Chai, Y., and Winans, S.C. 
The DNA binding domain of TraR contains amino acids that increase protease susceptibility. 
Figures 3.1, 3.2, 3.3 and Table 3.3 were done by Chai, Y. All the other Figures and tables 
were done by Costa, E.D.  
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and found that mutations in TraR-CTD previously shown to accumulate more 
than the wild-type protein also have an increased half-life. These combined 
results show that features found in TraRCTD enhance protease susceptibility. 
 
3.2. Introduction 
The cellular abundance of any protein is determined by its rate of 
synthesis, the rate at which cell division dilutes the protein, and the rate of its 
degradation by cellular proteases (Gottesman, 2003). In eukaryotic cells, 
protein degradation generally occurs after a protein is polyubiquitinated by a 
ubiquitin ligase (Glickman and Ciechanover, 2002). These covalently modified 
proteins then enter the 26S proteasome and are reduced to short peptides. 
Bacteria do not appear to covalently modify proteins to mark them for 
proteolysis, but nevertheless can selectively degrade certain proteins via 
several cytoplasmic proteases. These proteases are multisubunit complexes 
containing a substrate binding component that binds and unfolds the substrate 
protein at the expense of ATP, and a protease component whose active site 
lies within a hollow core of the complex (Gottesman, 1996). 
Many proteins are required only at particular times of the cell cycle or in 
response to particular environmental stimuli and they are removed from the 
cell by proteolysis at times that they are unneeded or even deleterious (Frank 
et al., 1996; Jenal and Fuchs, 1998; Turgay et al., 1998; Zhou et al., 2001). At 
least some of these proteins have evolved features that enhance protease 
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susceptibility. In general terms, hydrophobic residues that are exposed to the 
aqueous milieu are thought to act as a signal (Gottesman, 2003). Such a 
signal also serves to target denatured or misfolded proteins, as correctly 
folded proteins generally have hydrophobic interiors and hydrophilic exteriors.  
Hydrophobic residues on the exterior of a fully folded protein can also 
serve as a proteolysis signal. These sequences are frequently, though not 
always, found at the amino or carboxyl terminus of a protein. A particularly well 
studied example of this is the CtrA protein of Caulobacter crescentus. This 
protein regulates transcription of genes required for the progression through 
the cell cycle. CtrA accumulates during the G1 phase, regulates almost 100 
promoters, and then is degraded by the ClpXP protease (Jenal, 2009). CtrA 
has two alanine residues at its C-terminus that provide a target for proteolysis 
(Domian et al., 1997). 
 The TraR protein of Agrobacterium tumefaciens may provide another 
example of a protein with built-in protease recognition features. TraR is a 
LuxR-type quorum sensing transcription factor that binds an autoinducer-type 
pheromone (3-oxo-octanoylhomoserine lactone, OOHL) (Zhu and Winans, 
1999). TraR-OOHL complexes bind to the promoters of the Ti plasmid genes 
required for vegetative replication or for conjugative transfer (Fuqua and 
Winans, 1996; Fuqua and Winans, 1994; Li and Farrand, 2000; Pappas and 
Winans, 2003). TraR requires OOHL, not only for activity, but also for solubility 
and for folding into a protease-resistant form (Zhu and Winans, 1999, 2001). In 
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the absence of OOHL, apo-TraR is degraded by the Clp and Lon proteases, 
with a half-life of just 2 minutes (Zhu and Winans, 2001).  
TraR-OOHL complexes, while far more stable than apo-TraR, are 
nonetheless degraded at readily detectable rates, having a half life of 
approximately 35 minutes in A. tumefaciens (Zhu and Winans, 2001). This 
turnover could play an important role in turning off TraR activity, especially 
given the fact that TraR appears to bind OOHL irreversibly (Zhu and Winans, 
1999). One might expect that when cells with active TraR are diluted from a 
high to a low cell density, TraR would remain active. However, the degradation 
of TraR-OOHL complexes seems sufficiently rapid to eventually extinguish 
expression of its regulon. In the present study, we show that the C-terminal 
domain of TraR contains sites that destabilize the protein to proteolysis, and 
have mapped these sites.   
 
3.3. Materials and Methods 
Bacterial Strains, plasmids and oligonucleotides  
Bacterial strains and plasmids used in this study are described in Table 
3.1, while oligonucleotides used for PCR amplification and mutagenesis, 
obtained from Integrated DNA Technologies (Coralville, Iowa), are described 
in Table 3.2. A. tumefaciens strains were cultured in AT minimal medium at 
28°C (Tempé et al., 1977). Escherichia coli strains were cultured in Luria broth 
(LB) or solid medium at 37°C (Miller, 1972). Synthetic OOHL was provided by 
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A. Eberhard (Cornell University). Antibiotics were added at the following 
concentrations: 100 µg/mL spectinomycin, 100 µg/mL kanamycin, 200 µg/mL 
ampicillin and 10 µg/mL chloramphenicol for E. coli, and 200 µg/mL 
spectinomycin and 200 µg/mL kanamycin for A. tumefaciens.  
DNA manipulations  
Recombinant DNA techniques were performed using standard 
procedures (Sambrook and Russell, 2001). Plasmid DNA was isolated from E. 
coli with QIAprep spin miniprep kits (Qiagen) for DNA sequence analysis.  
DNA sequences of constructs that were obtained by PCR were verified using 
automated DNA sequencing (Cornell Biotechnology Resource Center) and 
analyzed using the LaserGene program (DNASTAR). Plasmids were 
introduced into E. coli by transformation (Sambrook and Russell, 2001) and 
into A. tumefaciens by electroporation (Cangelosi et al., 1991). E. coli strain 
DH5α was used for all plasmid constructions. 
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Table 3.1.  Strains and plasmids used in this study. 
Strains and 
plasmids 
Relevant genotypes Reference 
Strains   
DH5α  E. coli , α-complementation Stratagene 
KYC55 Agrobacterium tumefaciens  R10 lacking Ti plasmid (Cho et al., 1997) 
BL21/DE3 E. coli B Plac-gene 1 of bacteriophage T7 (Studier et al., 1990) 
SG22163 malP::lacIQ (Gottesman et al., 1998) 
SG22174 SG22163 clpP::cat (Gottesman et al., 1998) 
SG22186 SG22163 Dlon rcsA51::kan (Gottesman et al., 1998) 
KY2347 MG1655 D(clpPX-lon)1196::cat (Herman et al., 1998) 
KY2966 MG1655 DhslVU1172::tet (Herman et al., 1998) 
KY2981 MG1655 D(clpPX-lon)1196::cat DhslVU1172::tet 
sulA2981 
(Herman et al., 1998) 
Plasmids   
pHC012 pHC011 digested with EcoRV and KpnI and ligated 
to pBBR1-MCS5 after digestion with SphI and KpnI, 
with 3’-end fill-in of the SphI site with the Klenow 
fragment of DNA polymerase I; Ptac is fused to 
NdeI-KpnI-ApaI-XhoI-SalI-Bsp106I-ClaI-HindIII-
EcoRI-PstI-SmaI-BamHI-SpeI-XbaI-BstXI-SacI; rep-
pBBR1 GmR 
(Cho et al., 2009) 
pHC016 Full length TraR cloned into NdeI and BamHI sites of 
pHC012. GmR 
H. Cho 
pHC017 TraR-CTD (171-234) cloned into pRSETA (NdeI and 
HindIII sites were used). The first amino acid is 
methionine. AmpR 
H. Cho 
pKP105 TraR-NTD (1-170) was cloned into the NdeI and 
HindIII sites of pRSETA. AmpR  
K.M. Pappas 
pJZ358 TraR cloned into pRSETA (Zhu and Winans, 1999) 
pJBA27 Apr pUC18Not-PA1/0403-RBSII-gfpmut3*-T0-T1  (Andersen et al., 1998) 
pYC335 pYC335 traR cloned into EcoRI and BamHI sites of 
pPZP201  
(Chai and Winans, 2004) 
pMAL-C2 Expression vector which encodes maltose-binding 
protein (MBP) under control of Ptac promoter. 
New England Biolabs 
pCEW180A T180A substitution of TraR in pJZ335 (White and Winans, 2005) 
pCEW187E V187E substitution of TraR in pJZ335 (White and Winans, 2005) 
pCEW201A K201A substitution of TraR in pJZ335 (White and Winans, 2005) 
pCEW204A S204A substitution of TraR in pJZ335 (White and Winans, 2005) 
pCEW208A K208A substitution of TraR in pJZ335 (White and Winans, 2005) 
pCEW210A R210A substitution of TraR in pJZ335 (White and Winans, 2005) 
pCEW216W F216W substitution of TraR in pJZ335 (White and Winans, 2005) 
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Table 3.1. continued 
 
pYC107 TraR-CTD from pHC017 cloned into NdeI and HindIII 
of pHC012 
This study 
pYC360 GFP-TraR CTD with V187E substitution in TraRCTD This study 
pYC361 Plac-TraR with A186E substitution in TraR. SpecR This study 
pYC362 Plac-TraR with V187E substitution in TraR. SpecR This study 
pYC363 GFP-TraRCTD with K232E and L233S substitutions 
in TraRCTD 
This study 
pYC364 GFP-TraRCTD with L233D substitution in TraR-CTD This study 
pYC365 GFP-TraRCTD with I234D substitution in TraRCTD This study 
pEC514 T180A substitution of TraR from pCEW180A cloned 
into BbsI and HindIII sites of pJZ358 
This study 
pEC515 V187E substitution of TraR from pCEW180A cloned 
into BbsI and HindIII sites of pJZ358 
This study 
pEC517 K201A substitution of TraR from pCEW201A cloned 
into BbsI and HindIII sites of pJZ358 
This study 
pEC518 S204A substitution of TraR from pCEW204A cloned 
into BbsI and HindIII sites of pJZ358 
This study 
pEC519 K208A substitution of TraR from pCEW208A cloned 
into BbsI and HindIII sites of pJZ358 
This study 
pEC520 R210A substitution of TraR from pCEW210A cloned 
into BbsI and HindIII sites of pJZ358 
This study 
pEC521 F216W substitution of TraR from pCEW216W cloned 
into BbsI and HindIII sites of pJZ358 
This study 
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Table 3.2. Oligonucleotides used in this study 
 
traRCTD F1 5’-GTACGAATTCGCGGAAGATGCCGCA-3’ 
traRCTD F2 5’-GTACTGCAGAATTCGCGGAAGCTGCCGCA-3’ 
traRCTD R1 (insertion of two amino 
acids - SE at the end of TraRCTD)  
5’-GTACAAGCTTCACTCTGAGATGAGTTTCCGCC-3’ 
traRCTD R2 (L233S) 5’-GTACAAGCTTCAGATGGATTTCCGCCG-3’ 
traRCTD R3  5’-GCTCAGCTAATTAAGCTTCA-3’ 
traRCTD R4 (sequencing primer) 5’-GCAACCGAGCGTTCTGAACA-3’ 
traRCTD R5 (K232E) 5’-GTACAAGCTTCAGATGGATTCCCGCCGGATGGC-3’ 
traRCTD R6 (L233D) 5’-GTACAAGCTTCAGATGTCTTTCCGCCGGAT-3’ 
traRCTD R7 (I234D) 5’-GTACAAGCTTCAGTCGAGTTTCCGCCG-3’ 
traRCTD R8 (I185-A186-V187-stop 
codon) 
5’-CGTAAGCTTTCAGACGGCAATCCATCTCAG-3’ 
traRCTD R9 (I185-A186-stop codon) 5’-CGTAAGCTTTCAGGCAATCCATCTCAGATA-3’ 
traRCTD R10 (I185-stop codon) 5’-CGTAAGCTTTCAAATCCATCTCAGATAGGT-3’ 
traRCTD R11 (I185-A186E-V187-
stop codon) 
5’-CGTAAGCTTTCAGACTTCAATCCATCTCAGATAGG-
3’ 
traRCTD R12 (I185-A186-V187E-
stop codon) 
5’-CGTAAGCTTTCACTCGGCAATCCATCTCAGAT-3’ 
TraRCTD-M1 (A186E in full length 
TraR) 
5’-GAGATGGATTGAGGTCGGCAAGA–3’ 
TraRCTD M2 (V187E in full length 
TraR)  
5’-ATGGATTGCCGAGGGCAAGACGA–3’ 
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Immunodetection of TraR in vivo 
The abundance of each TraR protein was determined using strain 
KYC55 containing plasmids pHC012, pHC016, pYC107 or pYC108. The 
strains were cultured on 10 ml of AT medium supplemented with appropriate 
antibiotics, 500 µM IPTG and 250 nM OOHL. When cultures reached an 
OD600 of 0.5, they were centrifuged and the cell pellets were resuspended in 
5% of their original volume in 1x cracking buffer (125 mM Tris pH 6.8, 4% 
SDS, 20% glycerol, 200 mM DTT, 0.02% bromophenol blue). Cells were 
disrupted by boiling for 5 min, cooling and boiling for another 5 min. A fraction 
of each sample was size-fractionated using 15% SDS polyacrylamide gels, 
and electrophoretically transfered onto nitrocellulose membranes (BIORAD). 
The membranes were blocked using TBS (20 mM Tris pH 7.9, 500 mM NaCl, 
0.05% Tween 20) with 5% skim milk, and immunodetected in TBS with 
pre-adsorbed polyclonal anti-TraR rabbit antiserum (Chai and Winans, 2004). 
Goat anti-rabbit IgG conjugated with alkaline phosphatase (BIORAD) was 
used as the secondary antibody, and the membranes were stained with BCIP 
(5-bromo-4-chloro-3-indoyl phosphate p-toluidine salt) and NBT (p-nitro blue 
tetrazolium chloride) (BIORAD). Westerns were performed with fresh cell 
lysates for each strain at least three times.  
OOHL sequestration assay by TraR in whole cells 
A. tumefaciens strains KYC55(pYC107), KYC55(pYC108) and 
KYC55(pHC016) were used for OOHL sequestration assays as previously 
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described (Chai and Winans, 2004). All assays were performed twice with 
independent cultures. 
TraR stability in E. coli 
The measurement of TraR turnover was performed using 
BL21/DE3(pKP105), and BL21/DE3(pJZ358) to compare the stability of TraR-
NTD and full length TraR. DH5α(pMAL-C2), DH5α(pYC338), DH5α(pYC339) 
were used to compare the stability of MBP with the fusion proteins MBP-
TraRCTD and MBP-TraRCTD+SE. For the experiments with the mutants of 
TraR which are more stable than wild type TraR, the turnover of the protein 
was determined using strain BL21/DE3(pJZ358) (Zhu and Winans, 1999) or 
derivatives of pJZ358 carrying traR mutants. The experiments were performed 
as described previously (Zhu and Winans, 2001). 
Overexpression of MBP-TraRCTD 
Overnight stationary-phase cultures of DH5α(pMAL-C2) and 
DH5α(pYC338) were diluted 50-fold on LB with 400 µg/mL ampicillin  and 
incubated at 37°C to an OD600 of 0.4 before induction with 1 mM IPTG. The 
cultures were incubated until an OD600 of 1, and the bacterial cells were 
harvested by centrifugation. The cells were resuspended in TEDG buffer (200 
mM NaCl, 0.1% DTT and 0.1% protease inhibitor cocktail from Sigma-Aldrich) 
and lysed using a French pressure cell. The crude extract was separated into 
soluble and pellet fractions by ultracentrifugation at 45K for 30 minutes. 
Samples were loaded in 10% SDS-polyacrilamide gel. 
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Random mutagenesis PCR  
Random mutagenesis by error-prone PCR was performed using the 
primers TraRCTDF2 and TraRCTD R3 and the plasmid pYC350 (GFP-
TraRCTD) as a template. The PCR products and the plasmid pJBA113 were 
digested with PstI and HindIII. The transformants were selected for increased 
fluorescence compared to wild type under UV light. The candidates were 
sequenced using primerTraRCTD R4 and the fluorescence was quantified 
using Synergy HT from BioTek. The fluorescence intensity values were 
normalized by the OD600 to compensate for the variations in cell densities. 
Site-directed mutagenesis 
Site-directed mutagenesis of TraR was performed using synthetic 
overlap extension PCR (Sambrook and Russell, 2001). The plasmid pYC350 
was used as a template and amplified using Taq polymerase High Fidelity 
(Invitrogen). The restriction sites for PstI and HindIII were used to introduce 
mutated DNA fragments into the wild type gene. The forward primer 
TraRCTD-F1 and reverse primers (R1, R2, R5, R6, R7, R8, R9, R10, R11 and 
R12) were used to amplify TraR-CTD fragment with various substitutions 
(Table 3.2). Primers traRCTD-M1 and traRCTD-M2 were used to introduce 
site directed mutations (A186E and V187E) into full-length TraR using pYC335 
as a template. 
The fluorescence of each TraR allele, performed in DH5α (pYC350) or 
derivatives of pYC350 carrying each of the traR mutants, was determined 
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using synergy HT from BioTek. The fluorescence intensity values were 
normalized by the OD600 to compensate for the variations in cell densities. 
Protease deficient strains 
TraR turnover rates and accumulation were compared in the following 
protease-deficient strains of E. coli: SG22163 (malP::lacIQ), SG22174 
(SG22163 clpP::cat), SG22186 (SG22163 Dlon rcsA51::kan) (Gottesman et 
al., 1998), KY2347 (MG1655 D(clpPX-lon)1196::cat), KY2966 (MG1655 
DhslVU1172::tet), and KY2981 (MG1655 D(clpPX-lon)1196::cat 
DhslVU1172::tet sulA2981) (Herman et al., 1998). To quantitate TraR-CTD 
accumulation, the protease deficient strains containing the plasmid pYC350, 
which contains a fusion protein GFP-TraRCTD, were cultured in LB broth with 
appropriate antibiotics and IPTG to mid-logarithmic phase at 28°C. The 
fluorescence was measured using synergy HT from BioTek and normalized by 
the OD600 to compensate for the variations in cell densities. 
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3.4. Results 
TraR(1-170) is more stable than full length TraR 
We have previously found that TraR-OOHL complexes are detectably 
degraded in Agrobacterium tumefaciens, with a half-life of approximately 35 
minutes (Zhu and Winans, 1999). It was not clear whether particular parts of 
the protein caused this susceptibility. In the present study, we constructed 
three plasmids expressing Ptac- traR fusions, one expressing full length TraR, 
another expressing only the amino terminal domain of TraR (TraRNTD) 
(amino acid residues 1-170), and a third expressing only the carboxyl terminal 
domain of TraR (TraRCTD) (amino acid residues 171-234). The transcription 
and translation signals of all three genes are derived from the vector and are 
therefore identical. These plasmids were introduced into A. tumefaciens strain 
KYC55, which lacks a Ti plasmid, cultured to late log phase, and analyzed for 
TraR content by western immunoblotting.   
The strain expressing TraRNTD (1-170) accumulated a protein that was 
detected by the antiserum (Fig. 3.1, lane 5). This protein had a mass of 
approximately 19 Kda, in close agreement with the expected mass of this 
fragment (19.27 Kda). As expected, the abundance of this protein was far 
greater in the presence of OOHL than in its absence (Fig 3.1, lanes 4 and 5). 
The strain expressing full length TraR accumulated a protein of 27 Kda which 
has a mass identical to that of full length TraR (26.67 Kda) (Fig. 3.1, lane 7). 
The protein was not observed in the absence of OOHL (Fig 3.1, lanes 6). 
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Significantly, the full length protein observed at Fig. 3.1, lane 7 appeared to be 
less abundant than the TraRNTD(1-170) expressed from the truncated gene 
(Fig. 3.1, lane 5).  
We also used a strain expressing TraRNTD without the alpha-helix 9 
(145-162) which was previously shown to be important for dimerization (Pinto 
and Winans, 2009; Zhang et al., 2002). TraRNTD lacking alpha helix 9 is very 
unstable when overexpressed in A. tumefaciens from western blot (data not 
shown). The alpha-helix 9 is directly involved in dimerization and it was 
previously shown that dimerization enhances resistance of TraR to 
cytoplasmic proteolysis (Pinto and Winans, 2009).  
The A. tumefaciens strain expressing the TraRCTD(171-234) did not 
accumulate detectable levels of the corresponding TraR fragment with an 
expected size of 7 Kda (Fig 3.1, lanes 2 and 3). Similarly, E. coli strain DH5α 
(pYC107), which contains a Ptac-traR (171-234) fusion, failed to express 
detectable levels of the fragment, even when using immunodetection assays 
(data not shown). We also constructed a PT7-traR(171-234) fusion, expressed 
it using strain BL21/DE3, but failed to detect the fragment immunologically or 
using conventional protein stains (data not shown). These findings suggest 
that the TraRCTD(171-234) fragment is extraordinarily unstable to proteolysis, 
although the formal possibility remained that our polyclonal antiserum did not 
detect any epitopes present on this fragment. 
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Figure 3.1. N-terminal domain of TraR is more stable than the full-length 
TraR. (A) Western immunoblot of A. tumefaciens KYC55(pHC012) that does 
not contain TraR (lane 1), KYC55(pYC107) which express TraRCTD (lanes 2 
and 3), KYC55(pYC108) which express TraRNTD (lanes 4 and 5) or 
KYC55(pHC016) which express full length TraR (lanes 6 and 7). (B) OOHL 
sequestration assays of KYC55(pYC107), KYC55(pYC108) and 
KYC55(pHC016). (C) Pulse-chase experiments of A. tumefaciens 
KYC55(pYC108) which contains TraRNTD and KYC55(pHC016) which 
contains full length TraR. 
- + - + - +   (OOHL)
TraR
TraR-NTD
A
VC
+
B
S
e
q
u
e
s
te
re
d
 O
O
H
L
 (
p
M
)
0   4  16  64 128 256 0   4  16  64 128 256  (min)
TraR-NTD TraRC
Half-life (min)             > 256                   120
 105 
We used a second method to quantify the accumulation of TraR-OOHL 
complexes. We measured the sequestration of exogenous OOHL by whole 
cells that express full length TraR, TraRNTD(1-170), and TraRCTD(171-234). 
We cultured the three strains described above in the presence of OOHL, then 
washed the cells five times, extracted the OOHL using an organic solvent, and 
quantified the extracted OOHL using an A. tumefaciens  bioassay strain. As 
expected, the strain that expressed TraRCTD(171-234) did not sequester 
OOHL above background levels (data not shown), while the strains expressing 
full length TraR or TraRNTD(1-170) sequestered readily detectable amounts. 
Of these, the strain expressing TraRNTD(1-170) sequestered approximately 
2.5 times more OOHL than the strain expressing full length TraR (Fig. 3.1B). 
These data are supported by the western immunoblots described above, and 
indicate that TraRNTD(1-170) accumulates to higher levels than full length 
TraR.  
The greater abundance of TraRNTD(1-170) than full length TraR 
suggests that TraRNTD might be more stable to proteolysis. To test this 
directly, we expressed both proteins by using the T7 promoter, and performed 
pulse chase experiments using radiolabeled methionine. Full length TraR had 
a half life of approximately 120 minutes in E. coli (Fig. 3.1C), in reasonable 
agreement with previous measurements in this experimental system (Zhu and 
Winans, 2001). In contrast, TraRNTD(1-170) was not detectably degraded 
over a period of 4 hours.   
 
 106 
TraRCTD destabilizes MBP and GFP fusion proteins  
As described above, the TraRCTD appeared to destabilize the protein. 
When the C-terminal domain of TraR (TraR-CTD) was overexpressed in either 
E. coli or A. tumefaciens, it was never detectable even by western immunoblot 
(data not shown). To determine whether it could destabilize unrelated proteins, 
we constructed a translational fusion between TraRCTD and either maltose 
binding protein (MBP) or green fluorescent protein (GFP). When 
overexpressed in E. coli, the MBP-TraR(171-234) fusion protein accumulated 
to lower levels and was less soluble than MBP-LacZα (produced by the vector, 
Fig. 3.2A). The fusion protein was also degraded more rapidly than MBP-
LacZα in pulse labeling experiments (Fig. 3.2B). We made a similar fusion 
containing two additional amino acids, a serine and a glutamate, at the very 
end of TraRCTD. The addition of these two amino acids increased the 
accumulation of the fusion protein indicating that the amino acids at the C-
terminal end of the protein (Leu-Ile) might be involved in the destabilization of 
the fusion protein. 
Similar results were obtained using a GFP-TraR(171-234) fusion (3.3A). 
This fusion was expressed in E. coli using a Plac promoter. A strain 
expressing this fusion showed approximately 4-fold lower levels of 
fluorescence than a strain expressing a GFP control, indicating that TraR(171-
234) increased proteolysis of the fusion protein, or, conceivably, that it 
impaired the correct folding of the fusion ( Fig. 3.3A). 
 107 
 
 
 
 
Figure 3.2.  C-terminal domain of TraR bears proteolytic signals. (A) 
Overexpression of DH5α(pMAL-C2) expressing MBP-LacZα and 
DH5α(pYC338) expressing the fusion protein MBP-TraRCTD. Letters T, S and 
P represent total, soluble, and pellet fractions of the cell lysates, respectively. 
The SDS-PAGE was stained with Coomassie brilliant blue dye. (B) 
Pulse-chase experiment comparing DH5α(pMAL-C2) which contains MBP-
LacZα, DH5α(pYC338) which contains the fusion protein MBP-TraRCTD and 
DH5α(pYC339) which contains the fusion protein TraRCTD with two additional 
amino acids, Serine and Glutamate (SE), at the end of TraRCTD. Radiolabel 
was quantified using a Storm Phosporimager. Calculated half-lives are 
indicated at the bottom of the figure. 
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Figure 3.3. Fluorescence of GFP-TraRCTD fusion protein and genetic screen 
for amino acid residues in TraR-CTD that contain proteolytic signals. (A) A 
fusion protein between GFP and TraR-CTD is much less fluorescent 
compared to GFP itself. On the left, E. coli colonies expressing either GFP 
(upper) or GFP-TraRCTD fusion proteins (lower). On the right, fluorescence 
was measured from the same cells shown on the left. (B) Random 
mutagenesis of GFP-TraRCTD to search for mutations in traRCTD that might 
increase fluorescence activity of the mutant fusion protein. Stars (*) represent 
nonsense mutations in traRCTD that cause both truncation of the 
GFP-TraRCTD fusion protein and increased fluorescence of the mutant 
protein.  
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Identification of TraR-CTD residues that enhance proteolysis 
The GFP-TraRCTD(171-234) fusion protein described above was 
mutagenized using random mutagenesis PCR and screened for variants 
showing increased levels of fluorescence. We had hoped to isolate missense 
mutations that would resist proteolysis better than the parent fusion. To our 
surprise, all mutants that were found by this screen had nonsense codons 
within the TraR portion of the fusion protein (Fig. 3.3B). 
Of the 57 codons encoded in the TraRCTD(171-234), only 17 can be 
converted to a stop codon by single base change (Table 3.3). Of these 17 
codons, we recovered stop codons at only 5 positions, one each at codons 
173 and 177 (numbering from the start codon of full length TraR), and five stop 
codons at each of the codons 181, 183, and 184. All of these mutations lay 
near the N-terminus of the TraR(171-234) portion of the fusion protein (Fig. 
3.3B). The fact that nonsense mutations were never recovered at any codon 
downstream of codon 184 provided suggestive evidence that a protease 
recognition motif could lie fully or partly downstream of this codon. Codons 
184-187 encode the hydrophobic residues Trp-Ile-Ala-Val. A stop codon at 
position 188 would therefore create a C-terminus with four hydrophobic 
residues that might destabilize the protein. 
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Table 3.3.  Distribution of identified nonsense mutations in GFP-TraRCTD 
stable variants among the 17 codons that can be converted to a stop codon by 
single base change. 
 
TraR amino acid 
 residues* 
Occurrence of Independent 
Nonsense Mutations 
W173 1 
K177 1 
E178 0 
Y181 5 
R183 5 
W184 5 
K189 0 
E192 0 
I194 0 
E198 0 
K201 0 
Y202 0 
K208 0 
E211 0 
K214 0 
K221 0 
R230 0 
* Amino acid residues shown here are the ones in the C-terminal domain of 
TraR that can generate nonsense mutations with single nucleotide change. 
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In an effort to more finely dissect this possible protease recognition site, 
we used site-directed mutagenesis to construct the fusions GFP-TraR(170-
185), GFP-TraR(170-186) and GFP-TraR(170-187). These fusions end at 
Ile185, Ala186, and Val187, respectively. GFP-TraR(170-185) had relatively 
high levels of fluorescence (Fig. 3.4), suggesting that this fusion protein was 
relatively stable. In contrast, GFP-TraR(170-186) and GFP-TraR(170-187) 
were far less fluorescent, suggesting that Ala186 and Val187 were required for 
a protease recognition motif (PRM). We then mutated the gene encoding 
GFP-TraRCTD(170-187) to make its C-terminus more hydrophilic. We 
individually altered Ala186 and Val187 both to glutamate residues. Both 
mutations restored fluorescence to levels comparable to the GFP-TraR(170-
186) (Fig. 3.4). 
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Figure 3.4. Fluorescence Intensity of GFP-TraR(CTD) variants bearing 
truncations and substitutions in the first protease recognition motif (PRM). 
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We then determined whether mutations A186E or V187E would 
stabilize a GFP-TraR that includes the native C-terminus of TraR. These 
mutations were introduced into a gene expressing GFP-TraRCTD. In the full-
length fusion protein, mutation A186E did not increase fluorescence, while 
V187E caused a modest increase (Fig. 3.5). These findings suggested the 
existence of one or more additional protease recognition motifs downstream of 
codon 187. In an effort to identify such a region, we carried out a second 
round of mutagenesis of a fragment containing the A186E mutation, and 
screened for elevated fluorescence. One colony was identified that 
reproducibly showed greater fluorescence than its parent. This gene had a 
new mutation at codon 233, from Leu to Asp (L233D). This mutation increased 
the fluorescence of the A186E mutant 4.5 fold. We introduced the L233D 
mutation into the fusion gene that contained V187E mutation. The resulting 
fusion protein containing the V187E and L233D mutations also displayed 
around 4.5 fold increase in the level of fluorescence (Fig. 3.5). The combined 
point mutations in both the first PRM(V187E) and the second PRM(L233D) 
gave a higher fluorescent activity compared even to that of V187E (truncated). 
These data suggest that the TraR-CTD may contain two protease recognition 
motifs, one that includes residues 184-187, and one at or near the extreme C-
terminus of the protein. 
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Figure 3.5.  Fluorescent activities from E. coli cells expressing different GFP-
TraRCTD variants. 
 
We then carried out a similar search for the second PRM, the results 
from which were described in Fig. 3.6. When we added two amino acids at the 
end of TraRCTD, the fluorescence increased almost 8 fold, suggesting that the 
amino acids at the end of TraRCTD might be part of a second PRM. The 
increase in stability by adding two additional amino acids at the end of 
TraRCTD was also observed in the fusion protein MBP-TraRCTD (Fig. 3.2B). 
We individually altered amino acids L233 and I234, both to aspartate residues. 
Both mutations increased the levels of fluorescence when compared to wild 
type TraRCTD (Fig. 3.6).  
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Figure 3.6. Fluorescence activities of GFP-TraR(CTD) variants bearing 
mutations and substitutions in the second protease recognition motif (PRM).  
 
As shown in Table 3.3, Fig 3.4, Fig 3.5 and Fig 3.6, we discovered two 
putative protease recognition motifs (183RWIAV187) and (232KLI234) that 
when removed by truncation or by point mutation, increased the fluorescence 
of the fusion protein GFP-TraRCTD. These two PRMs are highlighted in the 
TraRCTD structure in Fig 3.7. 
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Figure 3.7. Structure of TraR-CTD with highlighted regions representing the 
first putative protease recognition motif (183-RWIAV-187) and the second 
recognition motif (233-LI-234) in TraR-CTD. 
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Clp, Lon and HslVU cause proteolysis of GFP-TraRCTD 
Agrobacterium tumefaciens has orthologous  genes of several E. coli 
proteases, including ClpP, ClpA, ClpS, ClpX, ClpB, Lon, HslV, HslU, HflX, HflC 
and HflK (Goodner et al., 2001; Wood et al., 2001). A model for protease 
function is described in Fig. 3.8.  
 
 
 
 
 
 
Figure 3.8. Model of Clp protease function. A specific sequence in the 
substrate (shown in yellow) is recognized the ATPase domain of the protease 
machinery. The substrate is unfolded with the hydrolysis of ATP and the 
unfolded substrate is translocated to the proteolytic core, where it is degraded 
yielding short peptides. Examples of ATPase: ClpA, ClpX, HslU and Lon. 
Examples of protease: ClpP, HslV and Lon. Figure from (Gottesman, 2003). 
 
We tested protease-deficient E. coli strains for fluorescence of the 
fusion protein GFP-TraRCTD in comparison with GFP. The single mutations in 
clpP or lon did not detectably increase the fluorescence of either GFP-
TraRCTD or GFP (Fig. 3.9). In contrast, a single mutant in hslV-hslVU and a 
clpP-clpX, lon double mutant showed an increase in fluorescence for the 
fusion protein GFP-TraRCTD. The fluorescence increased 5 fold in the hslVU 
cells and 3.5 fold in the clpPX and lon double mutant compared to the wild 
type cells (Fig. 3.9). The fluorescence of the GFP also increased in the hslVU 
mutant, but less than 2 fold. This indicates that HSLVU protease might have 
aa
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some effect on the stability of GFP. Our results show that ClpPX, Lon and 
HslVU proteases are involved in the degradation of GFP-TraRCTD.  
 
Figure 3.9. E. coli wild type and protease deficient strains expressing either 
GFP or GFP-TraRCTD fusion proteins. 
 
Other amino acids of TraR-CTD decrease protein stability 
In a previous study in our laboratory, mutations in amino acids located 
at the TraRCTD were found to accumulate to higher levels than the wild type 
TraR, as evaluated by western blots using full length TraR (White and Winans, 
2005). This provides further evidence that the wild type sequences at these 
positions may contribute to the instability of the protein. To test this 
hypothesis, we performed pulse chase experiments and found that the 
mutations that increased the accumulation of TraR also increased its half life 
(Fig. 3.10). 
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The half life of TraR was 212 minutes at the tested conditions in the 
presence of OOHL and 2 minutes in the absence of OOHL. This result is in 
agreement with previous results from our laboratory performed under the 
same conditions (Pinto and Winans, 2009). The half life of the TraR protein 
with mutant T180A increased to 309 minutes. It is important to note that this 
amino acid contacts amino acid W184 of the same TraR subunit and, 
interestingly, it is in the same α-helix as amino acids in the first protease 
recognition motif reported in the previous sections.  
TraR V187E has a half life of 407 minutes, almost two times longer than 
the wild type. In a previous study, this amino acid was reported to be involved 
in the contact between TraR and the RNA polymerase (White and Winans, 
2005). It also belongs to the first protease recognition motif, described in the 
previous sections. The other five mutants that accumulate more than wild type 
are in the TraR DNA recognition helix. Three of them are hydrophilic, K201, 
R208 and K210 and the other two are hydrophobic, S204A and F216. All of 
them have a longer half life than wild type TraR (Fig. 3.10). 
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Figure 3.10. Pulse chase of TraR protein with mutations in amino acids of the 
carboxi-terminal domain that were previously shown to accumulate to higher 
levels than the wild type protein (White and Winans, 2005). In the figure we 
show the accumulation and the half-life of each mutant in full lengthTraR. 
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3.5. Discussion 
In this study, we have shown that the two domains of TraR play 
antagonistic roles in the stability of the protein. TraRNTD(1-170) was not 
detectably degraded over four hours, while TraRCTD(171-234), did not 
detectably accumulate, even when driven by the extremely powerful T7 
promoter. Clearly, the stability of the full length protein is more similar to its N-
terminal domain than its C-terminal domain, suggesting that the N-terminal 
domain may assist the latter in folding. There are several examples of intra-
protein folding chaperones (Fox and Waugh, 2003; Gegg et al., 1997; LaVallie 
et al., 2003; Nakamura and Iwakura, 1999; Pelletier et al., 1998). Of course, all 
folding still requires OOHL, without which the full length protein and the NTD 
are both extremely unstable to proteolysis (Zhu and Winans, 1999, 2001). 
Evidence was presented that TraR residues W184, I185, A186, V187 
and L233 could destabilize TraR, possibly in conjunction with neighboring 
residues. Of these, I185, A186 and L233 are sequestered by the opposite 
subunit of a TraR dimer. They would be surface exposed in a TraR monomer 
or in a TraR dimer whose two C-terminal domains were dissociated. In 
contrast, W184 and V187 are exposed to solvent in the TraR dimer. These 
residues were previously found to be essential for positive control, and 
mutations at this position inhibit activation of target promoters in vivo (Costa et 
al., 2009; Qin et al., 2009; White and Winans, 2005). These studies suggested 
that these two residues make direct contact with RNA polymerase, and if so, 
might be protected from proteolysis by RNA polymerase. It therefore seems 
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possible that TraR monomers would present several protease-sensitive amino 
acids, while TraR dimers would present fewer residues, and TraR-RNA 
polymerase complexes would present none. 
The binding to DNA seems to have an effect on the stability of TraR as 
well. Our results indicate that residue R210, which makes direct contact with 
DNA (White and Winans, 2007) could also destabilize TraR. Neighboring 
amino acids, including K208 previously reported to contribute to the affinity of 
TraR to DNA (White and Winans, 2007), also seem to play a role in TraR 
stability. When TraR is bound to the DNA, these residues are protected from 
proteolysis. Therefore, TraR would be more stable in cells if it is in the active 
form, as a dimer, and if it is bound to DNA.  
In earlier studies, the surface of TraR was systematically mutated in a 
search for residues involved in the contact with the RNA polymerase (Costa et 
al., 2009; White and Winans, 2005). Of the 60 mutations constructed at 38 
positions in the C-terminal domain of TraR, nine mutations caused an increase 
in accumulation between 1.25 and 2 fold (White and Winans, 2005). In a 
similar study of the N-terminal domain 117 mutations were made at 103 
positions, none of which over-accumulated significantly (Costa et al., 2009). In 
this study we tested six of these mutants and found that all of them have a 
longer half life than wild type TraR. Together, this data provides additional 
evidence that the C-terminal domain of TraR targets the protein for proteolysis. 
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Residue Leu233 was identified as the second possible protease 
recognition site. Deletion of the C-terminal residue (Ile234) caused a strong 
defect in function (Luo et al., 2003), probably because the C-terminal carboxyl 
group forms an ionic bond with Arg230 of the opposite subunit (Vannini et al., 
2002; Zhang et al., 2002). Leu233 and Ile234 were each altered to alanine 
and valine, which caused a loss in positive control, DNA binding, and 
accumulation (White and Winans, 2005). It would be interesting to alter these 
residues to hydrophilic ones in an otherwise wild type protein. We have tested 
the addition of two extra TraR residues Ser235 and Glu236 at the end of 
TraRCTD and showed that the presence of these two amino acids increased 
the stability of the protein. This is further evidence that Leu233 and Ile234 
decrease TraR stability. Lys221-Lys232 of each subunit form an alpha helix 
that dimerizes with its counterpart of the opposite subunit. However, Leu233 
and Ile234 are not part of this helix. Leu233 is probably highly exposed to 
solvent, while Ile234 is somewhat more sequestered. It is tempting to 
speculate that these strongly hydrophobic residues may have evolved 
precisely to enhance protein turnover. This would be analogous to the two 
alanine residues at the C-terminus of the C. crescentus CtrA protein, which 
causes the protein to be degraded by the ClpXP protease (Jenal and Fuchs, 
1998; Jenal, 2009). In our study, we show that ClpXP, Lon and HSLVU 
proteases are involved in the degradation of TraRCTD. Apo-TraR was 
previously reported to be more stable in the double mutant clpPX, lon (Zhu 
and Winans, 2001). Lon and HSLVU were found to be involved in the 
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degradation of SulA, a cell division inhibitor, in E. coli (Kanemori et al., 1999; 
Seong et al., 1999). HslVU and Lon recognition sites were found to be distinct, 
but both lie in the center and in the C-terminal domain of SulA. These regions 
of SulA are involved in molecular interactions with other proteins and are also 
important for the function of the protein as an inhibitor of cell division (Nishii 
and Takahashi, 2003).  
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3CHAPTER 4  
The Antiactivator Protein TraM Targets the Quorum Sensing 
Transcription Activator TraR to Proteolysis 
 
4.1. Summary 
The tumor-inducing (Ti) plasmid of Agrobacterium tumefaciens encodes 
two proteins, TraI and TraR that enable it to communicate via diffusible acyl-
homoserine lactone (AHL) pheromones.  TraI synthesizes the pheromone, 
while TraR is a pheromone-dependent transcription factor.  TraR activity is 
inhibited by the TraM protein, by forming a complex containing two copies of 
each protein.  These complexes are unable to bind tra box DNA sequences.  
The fate of TraR-TraM complexes in the cell has not been investigated.  In this 
study, we show that TraM sharply decreased the accumulation of TraR in 
whole cells, indicating that TraM targets TraR for proteolysis.  In contrast, the 
TraM component of these complexes is not proteolyzed.  Point mutations in 
either protein that block antiactivation also block TraR proteolysis. 
 
 
 
 
 
 
 
 
3
Chapter 4 is a manuscript prepared for submission. Costa, E.D., and Winans, S.C. The 
antiactivator protein TraM targets the quorum sensing transcription activator TraR to 
proteolysis.  
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4.2. Introduction 
Many types of bacteria can monitor their population densities and 
coordinate a broad range of physiologies by exchanging chemical signals 
(Eberl and Riedel, 2011; Galloway et al., 2011; Ng and Bassler, 2009).  These 
communication systems require one or more proteins to synthesize and export 
the signal and one or more proteins to detect it.  Many proteobacteria 
synthesize acyl-homoserine lactone (AHL) signals via a protein that resembles 
LuxI of Vibrio fischeri, and detects AHLs via transcription factors that resemble 
LuxR (Pappas et al., 2004; Stevens et al., 2011). 
One of the best studied examples of this family of signaling systems is 
from in the plant pathogen Agrobacterium tumefaciens, which is responsible 
for the crown gall disease (White and Winans, 2007a).  The signal molecule is 
3-oxo-N-octanoyl homoserine lactone (OOHL), which is produced by the AHL 
synthase protein TraI, and detected by the AHL receptor TraR, which forms 
active homodimers. The dimerized TraR binds to specific sequences of DNA 
called tra boxes and activates transcription of the rep and tra operons, which 
direct vegetative replication and conjugative transfer, respectively (Fuqua et 
al., 1996; Pappas and Winans, 2003; Qin et al., 2000; White and Winans, 
2007b).  TraR is composed of two domains connected by a flexible linker. The 
amino terminal domain (NTD) contains the OOHL binding site and alpha-helix 
9 which mediates dimerization. The carboxyl terminal domain (CTD) contains 
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a four helix bundle that binds to the tra box DNA.  The CTD also contributes to 
protein dimerization (Zhang et al., 2002).  
TraR requires OOHL for folding into a protease resistant form, and in 
the absence of OOHL, it is degraded rapidly by the Clp and Lon proteases, 
with a half life of approximately 2 minutes, (Zhu and Winans, 2001).  TraR-
OOHL complexes are inhibited by two antiactivator proteins, TrlR and TraM.  
TrlR is a truncated form of TraR, which resembles TraR-NTD, and can form 
heterodimers with TraR that contain just one CTD and are therefore unable to 
bind DNA (Chai et al., 2001; Oger et al., 1998; Zhu and Winans, 1998). TraM 
is a small protein that forms a 1:1 complex with TraR.  TraR activates the 
transcription of the traM gene, creating a negative feedback loop (Fuqua et al., 
1995; Hwang et al., 1995).  
 The crystal structure of TraM revealed that TraM is a dimer with each 
subunit consisting of two long antiparallel helices.  The complex was also 
characterized in vitro demonstrating that TraM binds TraR with a 2:2 
stoichiometry (Chen et al., 2004; Vannini et al., 2004).  An orthologous 
complex containing TraR and TraM from Rhizobium sp. NGR234 was 
visualized by X-ray crystallography (Chen et al., 2007).  In this co-crystal, a 
dimer of TraM contacts a dimer of TraR, and each TraM subunit contacts both 
domains of TraR, more extensively the CTD, forcing the two CTDs apart, so 
that they cannot bind to a tra box (Chen et al., 2007).   
Little is known about the fate of TraM-TraR complexes after binding.  In 
this study we show TraR is degraded in the presence of TraM.  When TraR 
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mutants that interfere with the complex formation were used, the accumulation 
of TraR in the presence of TraM increased.  We also demonstrate that the 
concentration of TraM in the cells is independent of the concentration of TraR.  
From this, we can conclude that TraM targets TraR to proteolysis and that it 
itself is spared from that fate. 
 
4.3. Materials and Methods 
Bacterial strains, plasmids, and oligonucleotides 
 Bacterial strains and plasmids used in this study are listed in Table 4.1.  
A. tumefaciens strains were cultured in AT minimal medium at 28°C (Tempé et 
al., 1977).  Escherichia coli strains were cultured in LB medium.  Synthetic 
OOHL was provided by A. Eberhard (Cornell University).  Antibiotics were 
added to maintain plasmids at the following concentrations: 100 µg/mL 
spectinomycin, and 15 µg/mL gentamycin for E. coli; and 200 µg/mL 
spectinomycin and 200 µg/mL gentamycin for A. tumefaciens.  The 
oligonucleotides used in this study are listed in Table 4.2 and were obtained 
from Integrated DNA Technologies (Coralville, Iowa). Restriction enzymes 
were obtained from New England Biolabs. 
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Table 4.1. Bacterial strains and plasmids used in this study 
 
Strains Relevant genotype Reference 
NTL4 A. tumefaciens derivative of strain C58, 
lacking Ti plasmid 
(Luo et al., 2001) 
DH5α  E. coli , α-complementation Stratagene 
Plasmids   
pPZP200 Broad-host-range cloning vector, SpR  (Hajdukiewicz et 
al., 1994) 
pYC335  traR cloned into EcoRI and BamHI sites of 
pPZP201 
(Chai and Winans, 
2004) 
pSRKGent Broad-host-range cloning vector, replication 
and partitioning genes of pBBR1, GentR, 
lacIq 
(Khan et al., 2008) 
pEC500 TetR and Ptet cloned into pPZP200 This Study 
pEC501 traR cloned under control of PTet from Tn10 This Study 
pEC505 traM cloned into NdeI and BamHI sites of 
pSRKGent 
This Study 
pEC508 Flag-tag-traM cloned into NdeI and BamHI 
sites of pSRKGent 
This Study 
pEC526 182F substitution of TraR in pEC501 This Study 
pEC527 195T substitution of TraR in pEC501 This Study 
pEC528 195V substitution of TraR in pEC501 This Study 
 
 
DNA manipulations  
  Recombinant DNA techniques were performed using standard 
procedures (Sambrook and Russell, 2001).  Plasmid DNA was isolated from 
E. coli with QIAprep spin miniprep kits (Qiagen) for DNA sequence analysis.  
DNA sequences of constructs that were obtained by PCR were verified using 
automated DNA sequencing (Cornell Biotechnology Resource Center) and 
analyzed using the LaserGene program (DNASTAR).  Plasmids were 
introduced into E. coli by transformation (Sambrook and Russell, 2001) and 
 135 
into A. tumefaciens by electroporation (Cangelosi et al., 1991).  E. coli strain 
DH5α was used for all plasmid constructions. 
Plasmid construction 
 The construction of the plasmid pEC500 containing the Ptet and tetR 
was performed using transposon Tn10 as a template. A 783 bp fragment of 
Tn10 containing tetR, Ptet, operator regions, and 18 bp of tetA (three stop 
codons were added at the end of the tetA fragment) was amplified by PCR 
using the oligonucleotidesTn10 F and Tn10 R listed in Table 4.2. The resulting 
fragment was digested with EcoRI and SacI and cloned into the same 
restriction sites of pPZP200. The resulting plasmid is pEC500. 
To construct the plasmid expressing TraR, the traR gene was PCR 
amplified with the use of plasmid pYC335 (Chai and Winans, 2004) as a 
template and the oligonucleotides (TraR F and TraR R) listed in Table 4.2. The 
resulting DNA fragment was digested with KpnI and BamHI and cloned into 
pEC500 digested with the same enzymes, resulting in plasmid pEC501.  
The plasmid expressing TraM was constructed by amplifying traM from 
the genome of A. tumefaciens strain R10 using the oligonucleotides TraM F 
and TraM R listed in Table 4.2. The resulting PCR fragment was cloned into 
NdeI and BamHI sites of pSRKGent (Khan et al., 2008) resulting in pEC505. 
To construct Flag-TraM, the traM gene was PCR amplified using the 
oligonucleotides (Flag-tag-TraM F and TraM R) listed in Table 4.2.  The 
resulting fragment was digested using NdeI and BamHI and cloned into the 
same sites of pSRKGent (Khan et al., 2008) resulting in plamid pEC508.    
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Table 4.2. Oligonucleotides used in this study. 
Oligonucleotid
es 
Sequences 
Tn10 F 5’-GCTGAATTCTAACTCGACATCTTGGTTAC-3’ 
Tn10 R 5’-GCTGAGCTCTTATCACTACTTTGTCGAACTATTCAT-3’ 
TraR F 5’-GCTGGTACCTAGGAGGTATGGAATGCAGCAC-3’ 
TraR R 5’-GCTGGATCCACTTCGAACTCTCAGATGAG-3’ 
TraM F 5’-GCTCATATGATGGAACTGGAAGATGC-3’ 
TraM R 5’-GCTGGATCCTCAGTTGACGACCACCT-3’ 
Flag-tag-TraM 
F 
5’-
GCTCATATGGATTACAAGGATGATGATGATAAGGAATCG
GAAGAT GCAACATTG-3’ 
L182F F 5’-GCCACCTATTTCAGATGGAT-3’ 
L182F R 5’-ATCCATCTGAAATAGGTGGC-3’ 
A195T F 5’-GAGGAGATCACCGACGTCGA-3’ 
A195T R 5’-TCGACGTCGGTGATCTCCTC-3’ 
A195V F 5’-GAGGAGATCGTCGACGTCGA-3’ 
A195V R 5’-TCGACGTCGACGATCTCCTC-3’ 
 
Site-directed mutagenesis 
Site-directed mutagenesis of TraR was performed  using synthetic 
overlap extension PCR (Sambrook and Russell, 2001).  A 747 bp fragment of 
plasmid pEC501 was amplified using Taq polymerase High Fidelity 
(Invitrogen). The restriction sites for KpnI and BamHI were used to introduce 
mutated DNA fragments into the wild type gene.   
Immunodetection of TraR 
The abundance of each TraR and TraM was determined in A. 
tumefaciens in the following way.  A portion of each culture was centrifuged 
and the cell pellets were resuspended in 5% of their original volume in 1x 
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cracking buffer (125 mM Tris pH 6.8, 4% SDS, 20% glycerol, 200 mM DTT, 
0.02% bromophenol blue).  Cells were disrupted by boiling for 5 min, cooling 
to -80°C and boiling for another 5 min.  A fraction of each sample was 
size-fractionated using 12% SDS polyacrylamide gels, and electroblotted onto 
nitrocellulose membranes (BIORAD).  The membranes were blocked using 
TBS (20 mM Tris pH 7.9, 500 mM NaCl, 0.05% Tween 20) supplemented with 
5% skim milk. TraR was immunodetected in TBS with pre-adsorbed polyclonal 
anti-TraR rabbit antiserum (Chai and Winans, 2004) and goat anti-rabbit IgG 
conjugated with alkaline phosphatase (BIORAD) was used as the secondary 
antibody.  TraM was immunodetected in TBS with monoclonal anti-Flag M2 
antibody produced (Sigma-Aldrich).  Goat anti-mouse IgG conjugated with 
alkaline phosphatase (Jackson immunoResearch Laboratories) was used as 
the secondary antibody. The membranes were stained with BCIP 
(5-bromo-4-chloro-3-indoyl phosphate p-toluidine salt) and NBT (p-nitro blue 
tetrazolium chloride) (BIORAD).  Westerns were performed with fresh cell 
lysates for each strain at least three times.  Data were analyzed using ImageJ 
(http://rsb.info.nih.gov/ij/) (Rasband, 2004), and normalized against 
cross-reacting material in each lane.  
OOHL sequestration assay by TraR in whole cells 
A. tumefaciens strain NTL4 containing both pEC501 and pEC508 plasmids 
was used for OOHL sequestration assays as previously described (Chai et al., 
2001). 
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4.4. Results 
TraM enhances TraR proteolysis  
It was previously found that binding of TraM to TraR prevents TraR 
from binding DNA (Chen et al., 2007).  However, the ultimate fate of the TraR-
TraM protein complexes was not known.  To determine whether either of these 
proteins was degraded, we constructed two plasmids: pEC501, which express 
TraR constitutively from a Ptet promoter, and pEC508, which expresses Plac-
traM fusion, and also contains lacIQ, so that expression of the fusion can be 
controlled using IPTG. The plasmid pEC501 has a Ptet-TraR and encodes the 
repressor proteinTetR. The induction of the TraR expression should be 
controlled by the addition of anhydrotetracycline, but for unknown reasons, the 
expression of the Ptet-traR in pEC501 is constitutive. Even though expression 
of the traR gene was constitutive, the abundance of TraR protein was 
controlled using OOHL, as apo-TraR is degraded almost immediately.  These 
plasmids were introduced into A. tumefaciens strain NTL4, which lacks the Ti 
plasmid, cultured to late log phase in the presence of varying concentrations of 
OOHL and IPTG, and analyzed for TraR and TraM contents by western 
immunoblotting.  
  In experiments to detect TraR degradation, we used a low level of 
OOHL (0.1 nM) and varied concentrations of IPTG.  As expected, the 
abundance of TraM was highly responsive to IPTG concentration.  TraM was 
not detected after growth in the presence of 0, 40, or 80 µM IPTG, and 
expression was saturated by growth in 1280 µM (Fig 4.1 and Table 4.3).  
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Significantly, the abundance of TraM and TraR were inversely correlated.  As 
high levels of TraM, TraR was undetectable.  In control experiments, TraR did 
not accumulate in the absence of OOHL, and the addition of IPTG to cells 
lacking traM did not alter TraR abundance (data not shown).  
 
 
 
Figure 4.1. TraR degradation with increasing amounts of TraM . Western 
immunoblots of NTL4(pEC501)(pEC508) cells cultured in the presence of 0.1 
nM OOHL with different concentrations of IPTG (indicated in the top of the 
figure). 
 
We did similar experiments using higher concentrations of OOHL, 
which enhanced the abundance of TraR.  In the presence of 1 nM OOHL, 
ITPG caused a small decrease in TraR abundance, while in the presence of 
10 nM or 100 nM OOHL, IPTG had no effect (Table 4.3).  This provides 
suggestive evidence that TraM acts stoichiometrically rather than catalytically 
to degrade TraR. 
 
 
 
0      40     80   160    320   640 1280 2560 IPTG (µM) 
TraM 
TraR 
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Table 4.3. TraR accumulation using different concentrations of OOHL and 
IPTG. The accumulation was assessed by Western immunoblots.  
 
 TraR Abundance (% of TraR Abundance without IPTG)*  
OOHL 
(nM) 
IPTG (µM) 
 0 40 80 160 320 640 1280 2560 
0.1 100 98 71 26 14 11 < 10 < 10 
1 100 96 102 98 87 72 69 63 
10 100 NT NT NT NT 106 107 101 
100 100 NT NT NT NT 104 104 107 
* Accumulation was determined considering the protein and a load control 
(cross reacting material). NT: not tested  
 
A second method was used to confirm and quantify the accumulation of 
TraR in the presence or absence of TraM.  We measured the sequestration 
OOHL in the absence of IPTG or in the presence of 1 mM IPTG. We cultured 
cells expressing TraR and TraM or only expressing TraR in the presence of 
0.1 nM of OOHL , then washed the cells five times, extracted the OOHL using 
an organic solvent, and bioassayed the extracted OOHL. The strain 
expressing both TraR and TraM sequestered 90% less OOHL than the cell 
expressing only TraR (Fig.4.2). The sequestration of OOHL by the cells that 
do not express TraR was less than 1% (Fig 4.2).  These data confirm the 
western immunoblots described above, and indicate that TraM causes the 
destruction of TraR. 
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Figure 4.2. TraR sequesters less OOHL in the presence of TraM than in its 
absence. OOHL sequestration assays. The assay was performed using       
0.1 nM OOHL and 1 mM IPTG.  
 
Accumulation of TraR in the presence of TraM increases when the 
protein binding between TraR and TraM is impeded   
Previous studies have shown that particular amino acids in the carboxyl 
terminal domain of TraR are involved in the interaction with TraM  (Chen et al., 
2007; Luo et al., 2000; Qin et al., 2007).  TraR mutations L182F, A195T, and 
A195V interfere with antiactivation by TraM  (Luo et al., 2000; Qin et al., 2007).  
The abundance of TraR proteins containing these mutations was measured in 
the absence and presence of TraM.  As expected, TraM was not detected in 
the absence of IPTG, but could be detected when 1 mM of IPTG was used 
(Fig. 4.3A).   Also as expected, the abundance of wild type TraR was severely 
decreased by IPTG (compare Fig. 4.3B. lanes 1 and 2).  In contrast, 
TraR(L182F), TraR(A195T) and TraR(A195V) were still easily detected in the 
presence of IPTG (Fig 4.3B compare lanes 2, 4, 6, and 8).  The intensities of 
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these bands are quantified in Table 4.4.  The accumulation of TraR was not 
completely restored with the mutations (Fig 4.3B and Table 4.4). This result 
can be explained by the fact that the single mutations in TraR do not disrupt 
completely the interaction between TraM and TraR. In fact, these mutants 
were found to interfere with TraM/TraR binding, but they seem not to be 
directly involved in the interaction between the proteins (Chen et al., 2007; Qin 
et al., 2007). The possible role of these amino acids in the interaction between 
the proteins will be further discussed below. 
 
 
 
 
 
Figure 4.3. Mutations in TraR that interfere with the interaction between this 
protein and its antiactivator are more stable than wild type TraR in the 
presence of TraM. (A) Accumulation of TraM without the addition of IPTG (-) 
and with the addition of 1 mM of IPTG (+). (B) Western immunoblots of TraR 
in the presence or the absence of 1 mM IPTG.  
 
A)
TraM
- +IPTG 
IPTG          - +          - +            - +          - +    
TraR        Wild type           L182F                A195T            A195V 
B)
TraR
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Table 4.4. Accumulation of TraR wild type and mutants, L182F, A195T and 
A195V, in the presence or absence of TraM.  
 
 Accumulation* 
TraR No IPTG (no TraM) 1mM IPTG (TraM) 
Wild type 100 < 10 
L182F 100 44 
A195T 100 56 
A195V 100 67 
*the accumulation was calculated considering each allele of TraR without the 
addition of IPTG as 100% of accumulation. The intensity of the bands was 
normalized against a load control. 
 
TraM levels do not decrease with increasing amounts of active TraR 
Data in the previous section suggest that TraM targets TraR for 
proteolysis. We wanted to determine whether the converse is also true, that is, 
whether TraR can target TraM for degradation.  To test this, we cultured the 
same strain in the presence of 160 µM IPTG, and 0, 1, 10, 100, or 1000 nM 
OOHL.  This IPTG concentration causes a very low but detectable 
accumulation of TraM, while the varied OOHL concentrations result in different 
concentrations of TraR.    
As expected, increasing amounts of OOHL caused increasing 
abundance of TraR (Figure 4.4).  However, the abundance of TraM was 
constant in all cultures.  These results indicate that TraM is not degraded after 
interaction with TraR, and it may work as an adaptor that presents TraR to 
proteases.  
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Figure 4.4. The presence of TraR does not change TraM stability. Western 
immunoblots of TraM and TraR in the presence of 160 µM of IPTG and 
increasing concentrations of OOHL (indicated at the top of the figure). 
 
The traM leader sequence contains a 300 nucleotide highly conserved 
sequence.  
 It is far from clear what benefit would be obtained from the 
antiactivation of TraR by TraM.  If TraM is always induced by TraR and always 
opposes TraR function, why not simply make less TraR?  It seemed at least 
plausible that antiactivation might be responsive to an environmental stimulus, 
which could act either at the transcriptional level, post-transcriptional level, or 
at the protein level.  We noticed that the traM leader sequence is unusually 
long, and that it is strongly conserved, even more so than the traM coding 
sequences (Figure 4.5).  We used BLASTN to search for similar sequences in 
published DNA sequence databases, and chose ten such sequences for 
further analysis. All traM orthlogs have similar long upstream sequences, 
although it is not clear whether they are transcribed (Figure 4.6).  Additional 
similar sequences were found upstream of members of the XRE family of 
 
 
OOHL (nM)    0            1        10       100     1000
TraM
TraR
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transcription factors (Figure 4.6).  All homologous sequences were found in 
members of the alphaproteobacteria. The MFOLD algorithm was used to look 
for possible secondary structures of the traM leader of pTiR10.  A predicted 
structure with high stability was detected (Figure 4.7).  
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Figure 4.5.  Alignment of eight traM genes with upstream regions.  As seen above, the 
leader sequences are more strongly conserved than the traM reading frames. 
 147 
 
 
 
Figure 4.6.    The top four lines show conservation of the leader and traM 
gene in four plasmids.  The four middle lines show examples of sequences 
that resemble the traM leader and lie upstream of members of the Xre family 
of transcription regulators. The bottom two lines show homologs of the traM 
leader that lie upstream of genes that do not resemble traM.   
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Figure 4.7.  Predicted secondary structure of the traM leader of pTiR10      
(dG = -105.39).  
Start codon
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.   
4.5. Discussion 
In this study we sought to determine the fate of complexes containing 
TraR and TraM.  Our first hyphotesis was that TraR was degraded after being 
inactivated by TraM.  We demonstrated that, as expected, TraR levels 
decreased in the presence of TraM (Fig. 4.1).  To confirm that the interaction 
between TraR and TraM is involved in the observed degradation of TraR in 
our Western immunoblots, we constructed mutants in TraR (L182F, A195V 
and A195T) that were shown previously to be resistant to TraM inhibition (Luo 
et al., 2000).  The protein products of three TraR mutants were detected in 
higher abundance than the wild type protein in the presence of TraM by 
Western analysis.  The co-crystal structure of TraM and TraR from Rhizobium 
sp. NGR234 (Chen et al., 2007) showed that helices α10 and α11 of TraR 
have most of the amino acids involved in the interaction with TraM.  Residue 
L182 is present in α10 and residue A195 in α11.  L182 was shown to project 
its side chain into the groove formed between the two TraM alpha helices 
(Chen et al., 2007).  When we used these mutations in our study, they did not 
restore the accumulation of TraR to 100%. This result is in agreement with the 
fact that these mutations do not completely eliminate the interaction between 
TraR and TraM as described previously (Luo et al., 2000; Qin et al., 2007).  
The finding that the interaction between TraM and TraR causes a 
decrease in TraR abundance led us to test the accumulation of TraM in the 
presence of increasing levels of TraR.  The levels of TraM did not change 
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when different concentrations of active TraR were used (Fig. 4.4).  If any 
degradation had occurred, it should have been detectable, as we expressed 
TraM at low levels and expressed TraR at varying levels, including levels that 
were much higher than TraM (Table 4.3). Our results indicate that TraM 
targets TraR for proteolysis, and that TraM is not degraded in this process, 
suggesting that it could act catalytically in TraR degradation. 
A possible mechanism for TraR degradation is based on the fact that 
TraM causes an allosteric conformational change in TraR. This conformational 
change might expose amino acids that are recognized by proteases as 
degradation signals leading TraR to proteolysis.  However, TraM would have 
to be released from the complex before the degradation of TraR because our  
results suggest that TraM is not degraded with TraR.  
Another possibility is that TraM works as an adaptor protein which 
mediates the interaction between TraR and proteases, enhancing proteolysis 
of this transcription activator.  
In some cases, proteins are recognized directly by cellular proteases, 
while in other cases, substrate recognition can be mediated by proteins called 
adaptors. Adaptor proteins are normally small and they can deliver specific 
substrates to the proteases or they can also prevent degradation of specific 
substrates  (Dougan et al., 2002; Roman-Hernandez et al., 2009).  Some 
adaptor proteins that have been described in bacteria are: ClpS, RssB, and 
SspB in E. coli (Flynn et al., 2004; Zhou et al., 2001), and MecA and Ypbh in 
B. subtilis (Nakano et al., 2002; Turgay et al., 1997).  Some adaptors, such as 
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SspB, can regulate the degradation of different classes of proteins (Flynn et 
al., 2004).  Our results suggest that it is possible that TraM works as an 
adaptor protein which not only inactivates TraR, but also delivers it for 
degradation.  TraM is important to prevent unnecessary expression of the tra 
genes. 
 The adaptive benefit of TraM is far from clear.  One possibility is that 
TraM is optimally active only in response to some environmental condition.  If 
so, this stimulus could act at the level of traM transcription or translation or 
TraM function.  It may be of some significance that the traM transcript has a 
leader of approximately 300 nucleotides that is highly conserved, found 
upstream of a number of different genes, and that has a very strong predicted 
secondary structure.  The most obvious paradigm for such a sequence would 
be a riboswitch.  If this leader allowed transcription or translation of TraM only 
under certain conditions, those conditions would indirectly impact the 
abundance of TraR and the transcription of TraR-regulated genes.  We note 
that there appears to be a riboswitch that impacts the expression of traR (A.L. 
Flores Mireles, unpublished data) that is responsive to cytoplasmic methionine 
and cysteine.   
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CHAPTER 5 
Conclusions and Future Work Directions 
 
In this dissertation I have described the possible mechanism of 
transcription activation by the quorum sensing transcription activator protein 
TraR. I also showed that the carboxyl terminal domain of this protein is 
recognized for degradation and that the antiactivator protein, TraM, targets 
TraR to proteolysis.  
In chapter 2, the amino acids in the amino terminal domain of TraR that 
are important for the interaction with the RNA polymerase were identified. The 
patches of amino acids in TraR and their possible contacts with the alpha 
subunit or with another subunit of the RNA polymerase were discussed. In 
further studies, it would be interesting to identify which subunits of the RNA 
polymerase are participating in the interaction with each patch of TraR at class 
I and II promoters. Stop codon mutants were constructed at different positions 
on TraR surrounding the patches of amino acids found. The idea of this is to 
add unnatural amino acids to these stop codons by using engineered plasmids 
which encode tRNA synthetase and tRNA capable of incorporation of these 
unnatural aminoacids at the stop codons of TraR. One example of these 
plasmids is pEVOL which was obtained by our lab from the laboratory of Dr. 
Peter G. Schultz (The Scripps Research Institute). The use of unnatural amino 
acids, such as p-Benzoylphenylalanine, would allow crosslinking between 
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TraR and different subunits of the RNA polymerase. The position where the 
crosslinks occur in the RNA polymerase could be mapped by mass 
spectroscopy. Another experiment that could be done is the construction of 
point mutations in the alpha subunit and the region 4 of sigma of the RNA 
polymerase. Techniques such as in vitro transcription, surface plasmon 
resonance and fluorescence anisotropy could be performed with the mutants 
RNA polymerase and TraR to determine which amino acids of the RNA 
polymerase are involved in the interactions with this transcription factor.  
In chapter 3, it was shown that amino acids in the carboxyl terminal 
domains of TraR target the protein to proteolysis. It is fascinating that amino 
acids involved in the contacts between the TraR and DNA or TraR and RNA 
polymerase destabilize the protein. Amino acids buried in the dimer TraR and 
surface exposed in the monomeric protein are also targets for degradation. 
These results combined indicate that if TraR is monomeric or dimeric, but not 
bound to either DNA or RNA polymerase, it is automatically targeted for 
proteolysis.  
In Chapter 4, it was found that TraR is degraded after interaction with 
TraM, and that TraM is not degraded in this process, suggesting that TraM 
might work as an adaptor protein, increasing the rate of degradation of TraR. 
Another possibility is that the conformational change of TraR by TraM exposes 
amino acids that are recognized by proteases, resulting in proteolysis. Adaptor 
proteins increase specificity of proteases to substrate and accelerate their rate 
of degradation. The adaptor proteins bind to the ATPase domain of the 
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protease complexes and deliver the substrate to the processing pore site of 
the ATPase. It would be interesting to check if TraM interacts with ClpA, ClpX, 
Lon or HslU from A. tumefaciens. The interactions could be tested by bacterial 
two hybrid system or by crosslinking. If the interactions are verified, the amino 
acids involved in the interaction could be mapped and the mechanism of 
interaction and delivery of TraR to the proteases described. Adaptors are 
known to be well regulated by the cells. In Chapter 4 we also discussed the 
presence of a 300 bp untranslated leader sequence upstream of traM which 
was predicted to form a secondary structure. It would also be interesting to 
test the function of the leader sequence in the regulation of TraM. Resections 
of the leader sequence could be done and fused to LacZ. This leader 
sequence might be a riboswitch which is regulated by some small molecule. 
Further studies investigating the function of the leader sequence upstream of 
traM and the role of this protein as an adaptor between TraR and proteases 
could bring new insights about the regulation of TraR.  
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4APPENDIX  
Saturation Mutagenesis of a CepR Binding Site as a Means to 
Identify New Quorum-regulated Promoters in Burkholderia 
cenocepacia 
 
A.1. Summary 
Burkholderia cenocepacia is an opportunistic pathogen of humans that 
encodes two genes that resemble the acylhomoserine lactone synthase gene 
luxI of Vibrio fischeri and three genes that resemble the acylhomoserine 
lactone receptor gene luxR. Of these, CepI synthesizes octanoylhomoserine 
lactone (OHL), while CepR is an OHL-dependent transcription factor. In the 
current study we developed a strategy to identify genes that are directly 
regulated by CepR. Yuping Wei and I systematically altered a CepR binding 
site (cep box) upstream of a target promoter to identify nucleotides that are 
essential for CepR activity in vivo and in vitro for CepR binding. Yuping Wei 
constructed 34 self-complementary oligonucleotides containing altered cep 
boxes, and measured binding affinity for each. These experiments allowed us 
to identify a consensus CepR binding site. Several hundred similar sequences 
were identified by David Schneider and Stephen Winans, some of which were 
adjacent to probable promoters. Ana Flores-Mireles fused several such  
 
4 Wei, Y., Ryan, G.T., Flores-Mireles, A.L., Costa, E.D., Schneider, D.J., and 
Winans, S.C. (2011) Saturation mutagenesis of a CepR binding site as a 
mean to identify new quorum-regulated promoters in Burkholderia 
cenocepacia.  Mol Microbiol 79(3): 616-632.  
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promoters to a reporter gene with and without intact cep boxes. This allowed 
us to identify four new regulated promoters that were induced by OHL, and 
that required a cep box for induction. CepR-dependent, OHL-dependent 
expression of all four promoters was reconstituted in E. coli by Gina Ryan who 
showed that purified CepR bound to each of these sites in electrophoretic 
mobility shift assays. 
 
A.2. Introduction 
The genus Burkholderia encompasses a fascinating collection of 
diverse β-proteobacteria (Coenye and Vandamme, 2003). This genus includes 
over 50 species, some of which are potentially useful in bioremediation, while 
other members are capable of forming nitrogen-fixing root nodules with 
legumes (Bontemps et al., 2010; Chen et al., 2003). Some members protect 
host plants against fungal pathogens, while others are themselves pathogenic 
against plants, animals, and humans (Coenye and Vandamme, 2003; Jones 
and Webb, 2003). Seventeen pathogenic species are members of the 
Burkholderia cepacia complex, or BCC (Vandamme et al., 1997; Vanlaere et 
al., 2008; Vanlaere et al., 2009), two of which are described by the Center for 
Disease Control as category B select agents (Godoy et al., 2003). 
B. cenocepacia, previously known as B. cepacia genomovar III 
(Vandamme et al., 2003), is recognized as an opportunistic pathogen of 
humans and is a particular threat to cystic fibrosis (CF) patients 
(Mahenthiralingam et al., 2005; Vandamme et al., 1997). Colonization of the 
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CF lung by B. cenocepacia (Vandamme et al., 2003) tends to occur in patients 
already infected with Pseudomonas aeruginosa, another opportunistic 
pathogen of the CF lung (Jones and Webb, 2003; Vandamme et al., 1997). An 
infection caused by both organisms can result in serious clinical complications. 
B. cenocepacia strains are resistant to most antibiotics, making them virtually 
impossible to eradicate (Nzula et al., 2002). Infections with B. cenocepacia 
may have variable clinical outcomes ranging from asymptomatic carriage to a 
sudden fatal deterioration in lung function (Mahenthiralingam et al., 2005).   
Four strains of B. cenocepacia have been sequenced in their entirety, 
one of which is described in a publication (Holden et al., 2009). The Joint 
Genome Institute is currently sequencing nine additional strains 
(http://www.jgi.doe.gov/genome-projects/). All four sequenced isolates have 
three circular chromosomes that vary in size between 3.9 and 0.88 MB in 
length. Strains J2315 and HI2424 also have one plasmid, 93 KB and 165 KB 
in length, respectively. 
Many or possibly all Burkholderia spp. encode at least one regulatory 
system that resembles the LuxR and LuxI proteins of Vibrio fischeri, where 
LuxI synthesizes an acylhomoserine lactone (AHL)-type pheromone, also 
called an autoinducer, and LuxR is an AHL-dependent transcriptional regulator 
(Choi and Greenberg, 1992; Eberhard et al., 1981; Engebrecht and Silverman, 
1984). Regulatory systems of this family are found in countless proteobacteria, 
where they are thought to allow individual bacteria to coordinate their 
physiology with their siblings. Collectively, these systems regulate diverse 
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processes, including pathogenesis, biofilm formation, bacterial conjugation, 
and the production of antibiotics and other secondary metabolites (Whitehead 
et al., 2001). In general, target genes are transcribed preferentially at 
population densities high enough to favor AHL accumulation (Eberhard et al., 
1991), a phenomenon referred to as quorum sensing (Fuqua et al., 1994). B. 
thailandiensis has three such systems, one of which is implicated in cell 
aggregation, while another is required for antibiotic production (Chandler et al., 
2009; Duerkop et al., 2009). A plant growth promoting isolate of B. ambifaria 
uses quorum sensing to regulate the production of the anti-fungal compound 
pyrrolnitrin (Schmidt et al., 2009). 
LuxR-type proteins have two domains, an N-terminal pheromone 
binding domain and a C-terminal DNA binding domain (Pappas et al., 2004). 
Purified LuxR, TraR of Agrobacterium tumefaciens, and LasR of 
Pseudomonas aeruginosa, when complexed with their respective AHLs, bind 
with high specificity to recognition sequences (referred to as lux, tra, or las 
boxes, respectively) that are found at target promoters (Schuster et al., 2004; 
Urbanowski et al., 2004; Zhu and Winans, 1999). LasR is also able to bind to 
sequences that have no obvious resemblance to canonical las boxes. A few 
members of this family bind DNA only in the absence of AHLs (Castang et al., 
2006; Cui et al., 2005; Fineran et al., 2005; Minogue et al., 2005; Sjoblom et 
al., 2006).  
Burkholderia cenocepacia J2315 encodes three LuxR homologs and 
two LuxI homologs (Lewenza et al., 1999; Malott et al., 2005; Malott et al., 
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2009). Among these, CepR and CepI appear to be well conserved within the 
BCC (Venturi et al., 2004). CepI synthesizes primarily octanoylhomoserine 
lactone (OHL), and lower levels of hexanoylhomoserine lactone (HHL) (Aguilar 
et al., 2003b; Gotschlich et al., 2001; Huber et al., 2001; Lewenza et al., 
1999). Null mutations in cepI or cepR increased the production of the 
siderophore ornibactin, and decreased the production of secreted lipases and 
metalloproteases ZmpA and ZmpB (Kooi et al., 2006; Lewenza et al., 1999; 
Lewenza and Sokol, 2001; Sokol et al., 2003). CepI and CepR are also 
required for swarming motility and biofilm formation (Huber et al., 2001) and 
for pathogenicity in several animal models (Kothe et al., 2003; Sokol et al., 
2003). B. cenocepacia also expresses the CciI and CciR proteins, which are 
encoded on a genomic island called cci (cenocepacia island), that is 
associated with epidemic strains (Malott et al., 2005). The CepIR and CciIR 
systems extensively interact, in that CciR negatively regulates cepI, while 
CepR is required for expression of the cciIR operon (Malott et al., 2005). 
Transcriptional profiling studies indicate that CepR and CciR regulate many of 
the same genes, but do so in opposite ways (O'Grady et al., 2009). B. 
cenocepacia also encodes an orphan LuxR homolog called CepR2, which 
represses a cluster of genes that may direct production of an antibiotic or other 
secondary metabolite (Malott et al., 2009). 
In addition to transcriptional profiling several other approaches have 
been used to identify genes whose expression is influenced by CepR and/or 
OHL. In one study, the proteome of a wild type B. cenocepacia was compared 
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to that of a cepR mutant. Fifty-five proteins were found to be differentially 
expressed in the two strains, approximately 10% of all detected proteins 
(Riedel et al., 2003). In a second study, fragments of a B. cepacia strain were 
cloned into a promoter trap plasmid and introduced into an E. coli strain that 
expressed CepR (Aguilar et al., 2003a). Twenty-eight promoter fragments 
were identified as being induced by OHL, and in all cases, induction required 
CepR. In a third study, a library of B. cenocepacia DNA fragments were 
introduced into a plasmid containing a promoterless luxCDABE operon 
(Subsin et al., 2007). That study identified 58 OHL-inducible promoters and 31 
OHL-repressible promoters. Regulation of nine of these genes required CepR, 
while the others were not tested. Seven OHL-inducible genes were identified 
by screening a library of lacZ fusions (Weingart et al., 2005). Induction of all of 
these genes required CepR. Purified CepR-OHL complexes bound with high 
affinity and specificity to specific DNA sequences at two target promoters 
(Weingart et al., 2005). These binding sites contained a 16-nucleotide 
imperfect dyad symmetry and were centered approximately 44 nucleotides 
upstream of the transcription start sites. These two sites are to date the only 
experimentally confirmed CepR binding sites.  
Most of the studies described above do not distinguish whether a target 
promoter is controlled by CepR directly or indirectly. CepR could regulate a 
promoter indirectly, for example, by directly regulating an unknown regulatory 
gene whose product directly regulates that promoter. Alternatively, a CepR 
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mutation might perturb cellular physiology in such a way that various 
promoters are affected by secondary effects.  
To date, the most comprehensive study attempting to define the optimal 
CepR binding site was done by Chambers, Sokol, and colleagues (Chambers 
et al., 2006), who approached this question with an impressive combination of 
genetics and bioinformatics. Mutagenesis of the known CepR binding site 
within the cepI promoter completely abolished induction (Chambers et al., 
2006). The promoters of six genes known to be induced by OHL were used to 
formulate a consensus CepR binding motif (Chambers et al., 2006). This 
information was used to test eight additional candidate promoters, six of which 
were CepR-regulated. Ultimately, ten inducible promoters were used to refine 
the consensus sequence, and 57 possible CepR binding sites were identified 
upstream of various genes. 
The consensus motif identified in the Chambers study included the 
sequence CTG-N10-CAG, which has dyad symmetry. However, several other 
bases in the consensus did not preserve this symmetry, and some of those 
non-symmetric bases were said to be highly conserved (Chambers et al., 
2006). The partial dyad symmetry suggests that CepR binds DNA as dimer 
and that the two DNA binding domains have rotational symmetry. Although we 
have no proof of this, structural studies of a related protein support this idea 
(Vannini et al., 2002; Zhang et al., 2002). Several other LuxR-type proteins are 
thought to decode dyad symmetrical sequences (Antunes et al., 2008; White 
and Winans, 2007; Whitehead et al., 2001). In the present study, Gina T. Ryan 
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tested the 10 putative CepR binding sites described above for the ability to 
bind purified CepR-OHL complexes. Yuping Wei and I systematically resected 
and mutated a known CepR binding site, and Ana L. Flores-Mireles used the 
resulting information to identify four new promoters that are regulated directly 
by CepR. All four promoters are regulated by CepR in vivo, require their 
binding sites for regulation, and bind with high affinity to CepR-OHL in vitro. 
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A.3. Results 
Note that only the results corresponding to the experiments that I did for 
this study are shown here. For the other figures, see the published 
manuscript4. 
 
Systematic mutagenesis of a CepR-dependent promoter 
In a previous study, a series of 4 nucleotide alterations were made in 
the CepR binding site of the cepI promoter, and all such mutations that 
disrupted any part of this binding site blocked promoter activation by CepR 
(Chambers et al., 2006). In the current study, I have extended those findings 
by altering single nucleotides within and beyond this site (Fig. A.1). I altered 
each of these bases to its complement, fused the resulting promoters to lacZ, 
and measured their activity in vivo. I used a broad range of OHL 
concentrations, as low concentrations could unmask subtle phenotypes, while 
high concentrations might allow us to detect residual induction of strongly 
defective promoters. 
I was especially interested in the six conserved dyad symmetrical 
sequences (CTG-N10-CAG, positions -8 to +8, see Fig. A.1). Alteration of 
bases -8, -7, or -6 strongly inhibited the activation of this promoter by CepR, 
especially at low or intermediate OHL concentrations (Fig. A.1). The same was 
true of alteration of bases +6, +7, or +8. Alteration of most of the ten central 
residues (from -5 to +5) inhibited activation at low OHL concentrations but had 
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less effect at moderate or high concentrations. The A-3T mutation was an 
exception, as it had little effect on expression at any OHL concentration.  
Mutations at positions -9 or -10 caused moderate loss of induced 
expression, while mutations at +9 or +10 showed more severe defects. One 
explanation could be that mutations at +9 or +10 might alter sites required for 
RNA polymerase binding. The cep box is centered 44.5 nucleotides upstream 
of the transcription start site (Weingart et al., 2005), so any -35 motif should lie 
directly adjacent to the cep box. At positions +8 to +13 there is the sequence 
GTTACA, which resembles the E. coli consensus TTGACA at four positions. 
To learn whether these bases serve as a -35 sequence, I made several 
mutations to either weaken or strengthen the similarity to the E. coli consensus 
sequence. The mutation A+8T and T+10G were predicted to strengthen the -35 
motif. However, neither single mutation nor a double mutation increased the 
basal or induced expression (Fig. A.1). The mutation A+11C was predicted to 
decrease expression, but surprisingly, had the opposite effect. An A+13C was 
also predicted to weaken a -35 sequence, but had only a mild defect. These 
data strongly suggest that the sequence GTTACA is not a functional -35 site. 
However, the mutations in this region did have fairly strong phenotypes, and 
may therefore contribute in an undefined way to promoter expression.  
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Figure A.1. Mutagenesis of individual nucleotides within and adjacent to the 
CepR binding site of the cepI promoter. Bases are numbered relative to the 
center of the axis of rotational symmetry, which is indicated using inverted 
arrows. Fusions were introduced into strain K56 I2, which lacks CepI. Strain 
K56 and its derivatives are naturally Lac-. Expression of each PcepI-lacZ 
fusion was measured for β-galactosidase specific activity (Miller, 1972) in the 
presence of the indicated concentrations of OHL.  
 
 
 
[OHL] (nM)
0   0.1   1.0     10
... gtcacc ctgtaaga gttaccag ttacaggctcctc... 24   248  1021   1096 
... gtcTcc ctgtaaga gttaccag ttacaggctcctc... 29   233   642    789
... gtcaGc ctgtaaga gttaccag ttacaggctcctc... 37   226   570    639
... gtcacG ctgtaaga gttaccag ttacaggctcctc... 28    98   275    545
... gtcacc Gtgtaaga gttaccag ttacaggctcctc... 41    76    64     91    
... gtcacc cAgtaaga gttaccag ttacaggctcctc... 26    47    38    147
... gtcacc ctCtaaga gttaccag ttacaggctcctc... 32    40    62    264
... gtcacc ctgAaaga gttaccag ttacaggctcctc... 32    31   233    584
... gtcacc ctgtTaga gttaccag ttacaggctcctc... 19    79   654    580
... gtcacc ctgtaTga gttaccag ttacaggctcctc... 55   122   778   1110
... gtcacc ctgtaaCa gttaccag ttacaggctcctc... 23    53   341    527
... gtcacc ctgtaagT gttaccag ttacaggctcctc... 28    71   538    394
... gtcacc ctgtaaga Cttaccag ttacaggctcctc... 24    90   473    425
... gtcacc ctgtaaga gAtaccag ttacaggctcctc... 20    40   183    209
... gtcacc ctgtaaga gtAaccag ttacaggctcctc... 16    41   221    553
... gtcacc ctgtaaga gttTccag ttacaggctcctc... 11    33   399    547
... gtcacc ctgtaaga gttaGcag ttacaggctcctc...  6    59   593    699
... gtcacc ctgtaaga gttacGag ttacaggctcctc... 27    78    67    713
... gtcacc ctgtaaga gttaccTg ttacaggctcctc... 15    35    53    101
... gtcacc ctgtaaga gttaccaC ttacaggctcctc... 23    27    57    150
... gtcacc ctgtaaga gttaccag Atacaggctcctc... 23    22    54     43
... gtcacc ctgtaaga gttaccag tAacaggctcctc... 29    35   162     97
... gtcacc ctgtaaga gttaccag ttTcaggctcctc... 22    76   489    414
... gtcacc Atgtaaga gttaccag ttacaggctcctc... 50    65    82    135
... gtcacc ctgtaaga gttaccaT ttacaggctcctc... 42    53    44     34
... gtcacc ctgtaaga gttaccag ttCcaggctcctc...181   354  1407   1387
... gtcacc ctgtaaga gttaccag tGacaggctcctc... 92   272   271    197
... gtcacc ctgtaaga gttaccaT tGacaggctcctc... 44    57    62     55
... gtcacc ctgtaaga gttaccag ttaAaggctcctc... 24    29   131     94
... gtcacc ctgtaaga gttaccag ttacCggctcctc... 33   117   625    586
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A.4. Discussion 
See the published manuscript4.  
 
A.5. Experimental Procedures 
Note that only the procedures for the experiments that I did are 
described here. See the published manuscript4 for the complete experimental 
procedures for this study. 
 
Bacterial strains and growth conditions  
Strains used in this study are described in Table A.1.  As needed, B. 
cenocepacia was cultured in 100 μg/ml of trimethoprim or 300 μg/ml of 
tetracycline. E. coli strains were cultured with 15 μg/ml of tetracycline, 100 
μg/ml of streptomycin, or 100 μg/ml of ampicillin. 
 
Systematic mutagenesis of the cepI promoter 
Single-site mutations in the cepI promoter were constructed by 
site-directed mutagenesis using oligonucleotides listed in Table A.2 (IDT, 
Coralville, Iowa). PCR fragments containing the desired mutations were 
cloned into the KpnI and PstI sites of pYW302, introduced into E. coli strain 
DH5α by transformation, checked by automated DNA sequencing (Cornell 
Biotechnology Resource Center), and then introduced into B. cenocepacia 
strain K56 I2 by electroporation (Cangelosi et al., 1991). Transformants were 
cultured in LB medium at 37O C to mid log phase (OD600 of 0.3-0.4), then 
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diluted 20-fold into LB medium containing 0, 0.1 nM, 1 nM or 1 μM OHL. 
Cultures were incubated at 37O C with aeration until an OD600 of approximately 
0.5, and then assayed for β-galactosidase specific activity (Miller, 1972). B. 
cenocepacia is naturally Lac-. Experiments were performed in triplicate with 
three different isolates of each strain.  
 
Table A.1. Strains and Plasmids 
Strains Relevant features Reference 
K56-I2 B. cenocepacia K56 cepI::TpR (Lewenza et 
al., 1999)  
DH5α  E. coli α-complementation Stratagene 
Plasmids  
 
 
 
pKP302 Broad host range, promoterless lacZ gene, Km
R
 (Pappas and 
Winans, 
2003)  
pYW302 Derivative of pKP302 expressing Tc
R
 This study 
pYW313 Wild type cepI promoter cloned into pYWN302 This study 
pEC300 Same as pYW313, but with substitution at position -11 (A to 
T) of the cep box, oligonucleotides EDC300 and YWP157 
This study 
pEC301 Same as pYW313, but with substitution at position. -10 (C to 
G) of the cep box, oligonucleotides EDC301 and YWP157 
This study 
pEC302 Same as pYW313, but with substitution at position -9 (C to 
G) of the cep box, oligonucleotides EDC302 and YWP157 
This study 
pEC303 Same as pYW313, but with substitution at position -8 (C to 
G) of the cep box, oligonucleotides EDC303 and YWP157 
This study 
pEC304 Same as pYW313, but with substitution at position -7 (T to 
A) of the cep box, oligonucleotides EDC304 and YWP157 
This study 
pEC305 Same as pYW313, but with substitution at position -6 (G to 
C) of the cep box, oligonucleotides EDC305 and YWP157 
This study 
pEC306 Same as pYW313, but with substitution at position -5 (T to 
A) of the cep box, oligonucleotides EDC306 and YWP157 
This study 
 
pEC307 
Same as pYW313, but with substitution at position -4 (A to 
T) of the cep box, oligonucleotides EDC307 and YWP157 
This study 
pEC308 Same as pYW313, but with substitution at position -3 (A to 
T) of the cep box, oligonucleotides EDC308 and YWP157 
This study 
pEC309 Same as pYW313, but with substitution at position -2 (G to 
C) of the cep box, oligonucleotides EDC309 and YWP157 
This study 
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Table A.1. (Continued) 
 
pEC310 Same as pYW313, but with substitution at position -1 (A to 
T) of the of the cep box, oligonucleotides EDC310 and 
YWP157 
This study 
pEC311 Same as pYW313, but with substitution at position +1 (G to 
C) of the cep box, oligonucleotides EDC311 and YWP157 
This study 
pEC312 Same as pYW313, but with substitution at position +2 (T to 
A) of the cep box, oligonucleotides EDC312 and YWP157 
This study 
pEC313 Same as pYW313, but with substitution at position +3 (T to 
A) of the cep box, oligonucleotides EDC313 and YWP157 
This study 
pEC314 Same as pYW313, but with substitution at position +4 (A to 
T) of the cep box, oligonucleotides EDC314 and YWP157 
This study 
pEC315 Same as pYW313, but with substitution at position +5 (C to 
G) of the cep box, oligonucleotides EDC315 and YWP157 
This study 
pEC316 Same as pYW313, but with substitution at position +6 (C to 
G) of the cep box, oligonucleotides EDC316 and YWP157 
This study 
pEC317 Same as pYW313, but with substitution at position +7 (A to 
T) of the cep box, oligonucleotides EDC317 and YWP157 
This study 
pEC318 Same as pYW313, but with substitution at position +8 (G to 
C) of the cep box, oligonucleotides EDC318 and YWP157 
This study 
pEC319 Same as pYW313, but with substitution at position +9 (T to 
A) of the cep box, oligonucleotides EDC319 and YWP157 
This study 
pEC320 Same as pYW313, but with substitution at position +10 (T to 
A) of the cep box, oligonucleotides EDC320 and YWP157 
This study 
pEC321 Same as pYW313, but with substitution at position +11 (A to 
T) of the cep box, oligonucleotides EDC321 and YWP157 
This study 
pEC322 Same as pYW313, but with substitution at position -8 (C to 
A) of the cep box, oligonucleotides YWP258 and YWP157 
This study 
pEC323 Same as pYW313, but with substitution at position +8 (G to 
T) of the cep box, oligonucleotides YWP255 and YWP157 
This study 
pEC324 Same as pYW313, but with substitution at position +11 (A to 
C) of the cep box, oligonucleotides EDC322 and YWP157 
This study 
pEC325 Same as pYW313, but with substitution at position +10 (T to 
G)of the cep box, oligonucleotides YWP256 and YWP157 
This study 
pEC326 Same as pYW313, but with substitution at positions +8 (G to 
T) and +10 (T to G) of the cep box, oligonucleotides 
YWP257 and YWP157 
This study 
pEC327 Same as pYW313, but with substitution at position +12 (C to 
A) of the cep box, oligonucleotides EDC323 and YWP157 
This study 
pEC328 Same as pYW313, but with substitution at position +13 (A to 
C) of the cep box, oligonucleotides EDC324 and YWP157 
This study 
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Table A2. Oligonucleotides. 
 
 
 
Name 
 
Sequence 
 
 Comments 
 
EDC300 
 
GCTGGTACCACGCCGTCTCCCTGTAAGAGTTACCAG 
 
For generating -
11T mutation  
 
EDC301 
 
GCTGGTACCACGCCGTCAGCCTGTAAGAGTTACCAG 
 
For generating -
10G mutation 
 
EDC302 
 
GCTGGTACCACGCCGTCACGCTGTAAGAGTTACCAG 
 
For generating -
9G mutation 
 
EDC303 
 
GCTGGTACCACGCCGTCACCGTGTAAGAGTTACCAG 
 
For generating 
B8G mutation 
 
EDC304 
 
GCTGGTACCACGCCGTCACCCAGTAAGAGTTACCAGTTACAG 
 
For generating -
7A mutation 
 
EDC305 
 
GCTGGTACCACGCCGTCACCCTCTAAGAGTTACCAGTTACAG 
 
For generating -
6C mutation 
 
EDC306 
 
GCTGGTACCACGCCGTCACCCTGAAAGAGTTACCAG 
 
For generating -
5A mutation 
 
EDC307 
 
GCTGGTACCACGCCGTCACCCTGTTAGAGTTACCAG 
 
For generating -
4T mutation 
 
EDC308 
 
GCTGGTACCACGCCGTCACCCTGTATGAGTTACCAG 
 
For generating -
3T mutation 
 
EDC309 
 
GCTGGTACCACGCCGTCACCCTGTAACAGTTACCAGT 
 
For generating -
2C mutation 
 
EDC310 
 
GCTGGTACCACGCCGTCACCCTGTAAGTGTTACCAGT 
 
For generating -
1T mutation 
 
EDC311 
 
GCTGGTACCACGCCGTCACCCTGTAAGACTTACCAGT 
 
For generating 
+1C mutation 
 
EDC312 
 
GCTGGTACCACGCCGTCACCCTGTAAGAGATACCAGT 
 
For generating 
+2A mutation 
 
EDC313 
 
GCTGGTACCACGCCGTCACCCTGTAAGAGTAACCAGTTAC 
 
For generating 
+3A mutation 
 
EDC314 
 
GCTGGTACCACGCCGTCACCCTGTAAGAGTTTCCAGTTAC 
 
For generating 
+4T mutation 
 
EDC315 
 
GCTGGTACCACGCCGTCACCCTGTAAGAGTTAGCAGTTAC 
 
For generating 
+5G mutation 
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Table A.2. (Continued) 
 
EDC316 
 
GCTGGTACCACGCCGTCACCCTGTAAGAGTTACGAGTTACAGGCTCCTCGT 
 
For 
generating 
+6G 
mutation 
 
EDC317 
 
GCTGGTACCACGCCGTCACCCTGTAAGAGTTACCTGTTACAGGCTCCTCGT
G 
 
For 
generating 
+7T 
mutation 
 
EDC318 
 
GCTGGTACCACGCCGTCACCCTGTAAGAGTTACCACTTACAGGCTC 
 
For 
generating 
+8C 
mutation 
 
EDC319 
 
GCTGGTACCACGCCGTCACCCTGTAAGAGTTACCAGATACAGGCTC 
 
For 
generating 
+9A 
mutation 
 
EDC320 
 
GCTGGTACCACGCCGTCACCCTGTAAGAGTTACCAGTAACAGGCTC 
 
For 
generating 
+10A 
mutation 
 
EDC321 
 
GCTGGTACCACGCCGTCACCCTGTAAGAGTTACCAGTTTCAGGCTC 
 
For 
generating 
+11T 
mutation 
 
YWP258 
 
GGGGTACCACGCCGTCACCATGTAAGAGTTACCAGTTACAG 
 
For 
generating 
-8A 
mutation 
 
YWP255 
 
GGGGTACCACGCCGTCACCCTGTAAGAGTTACCATTTACAGGCTCCTCGTG
C 
 
For 
generating 
+8T 
mutation 
 
EDC322 
 
GCTGGTACCACGCCGTCACCCTGTAAGAGTTACCAGTTCCAGGCTC 
 
For 
generating 
+11C 
mutation 
 
YWP256 
 
GGGGTACCACGCCGTCACCCTGTAAGAGTTACCAGTGACAGGCTCCTCGTG
CCG 
 
For 
generating 
+10G 
mutation 
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Table A.2. (Continued) 
 
 
 
 
 
 
 
 
 
 
 
 
 
YWP257 
 
GGGGTACCACGCCGTCACCCTGTAAGAGTTACCATTGACAGGCTCCTCGTG
CCG 
 
For 
generating 
+8T +10G 
mutation 
 
EDC323 
 
GCTGGTACCACGCCGTCACCCTGTAAGAGTTACCAGTTAAAGGCTC 
 
For 
generating 
+12A 
mutation 
 
EDC324 
 
GCTGGTACCACGCCGTCACCCTGTAAGAGTTACCAGTTACCGGCTC 
 
For 
generating 
+13C 
mutation 
 
YWP157
  
 
AACTGCAGGCCGATAGCGCCCGAGATCC 
 
Reverse 
primer for 
PCR 
amplifying 
mutant 
cepI 
promoters 
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